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  Inner	  cell	  mass	  	  iPSC	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Induced	  pluripotent	  stem	  cell	  iNC	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Induced	  neuronal	  cell	  iMN	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Induced	  motor	  neuron	  KO	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Knock-­‐out	  	  LP	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Lateral	  pallium	  	  LoF	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Loss-­‐of-­‐function	  	  MEF	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Mouse	  embryonic	  fibroblast	  MP	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Medial	  pallium	  	  MZ	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Marginal	  zone	  	  NSC	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Neural	  stem	  cell	  	  NCSC	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Neural	  crest	  stem	  cells	  	  NPC	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Neural	  progenitor	  cells	  	  PP	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Preplate	  	  PNS	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Peripheral	  nerve	  system	  	  SP	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Subplate	  	  SVZ	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Sub	  ventricular	  zone	  TH	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Tyrosine	  hydroxylase	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Chapter	  1:	  Introduction	  
	  
1.1	  Telencephalon	  development	  and	  neurogenesis	  
1.1.1	  Development	  of	  embryonic	  telencephalon	  The	  cerebrum	  is	  the	  most	  complex	  region	  of	  the	  vertebrate	  central	  nerve	  system	  (CNS),	  which	  is	  raised	  from	  the	  embryonic	  structure	  telencephalon.	  The	  embryonic	   telencephalon	   can	   be	   divided	   into	   two	   regions:	   the	   dorsal	   region	  (pallium),	   which	   develops	   into	   the	   cerebral	   cortex	   and	   generates	   excitatory	  glutamatergic	  projection	  neurons;	   the	  ventral	   region	   (subpallium),	  which	  gives	  rise	   to	   the	   basal	   ganglia	   and	   is	   the	   birth	   place	   of	   inhibitory	   GABAergic	  interneurons,	  which	  later	  migrate	  dorsally	  into	  the	  cortex.	  	  During	   embryonic	   development,	   the	   embryonic	   telencephalon	   can	   be	  divided	   into	   distinct	   progenitor	   domains	   along	   the	   dorsal-­‐ventral	   (D-­‐V)	   axis,	  which	  generate	  different	  parts	  of	  the	  adult	  brain	  (known	  as	  the	  D-­‐V	  patterning):	  the	  medial	  pallium	  (MP)	  gives	  rise	  to	  the	  archicortex	  and	  the	  hippocampus;	  the	  dorsal	  pallium	  (DP)	  develops	  into	  the	  anlage	  of	  the	  neocortex;	  the	  lateral	  pallium	  (LP)	   generates	   the	   olfactory	   cortex;	   the	   ventral	   pallium	   (VP)	   generates	   the	  claustroamygdaloid	   complex;	   the	   lateral	   (LGE)	   and	   medial	   (MGE)	   ganglionic	  eminences	   generate	   the	   striatum	   and	   pallidum	   (Figure	   1.1,	   reviewed	   in	  Schuurmans	   and	   Guillemot,	   2002).	   The	   initial	   patterning	   is	   defined	   by	  extracellular	  signals.	  The	  dorsal	  telencephalon	  patterning	  is	  primarily	  regulated	  by	   bone	  morphogenetic	   proteins	   (BMPs,	   provided	   by	   the	   roof	   plate)	   and	  Wnt	  (released	  from	  dorsal	  midline)	  signalling	  pathways	  (reviewed	  by	  Jessell,	  2000).	  Later	  studies	  also	  suggest	  that	  zinc-­‐finger	  protein	  GLI3	  may	  also	  involved	  in	  the	  dorsal	  telencephalon	  patterning	  by	  repressing	  ventralizing	  Sonic	  hedgehog	  (Shh)	  signals	   in	   the	   dorsal	   region	   (Rallu	   et	   al,	   2002).	   The	   ventral	   telencephalon	  patterning	  is	  regulated	  by	  the	  Shh,	  which	  is	  secreted	  by	  the	  floor	  plate	  (Grove	  et	  al,	  1998	  and	  Figure	  1.1).	  At	  embryonic	  day	  12.5	  (E12.5),	  homeodomain	  and	  basic	  helix-­‐loop-­‐helix	  (bHLH)	  transcriptional	  factors	  (TFs)	  become	  highly	  expressed	  in	  the	  developing	  telencephalon	  and	  the	  cross-­‐regulatory	  interactions	  between	  and	  within	  the	  2	  groups	  of	  TFs	  are	  essential	  for	  maintaining	  the	  progenitor	  identity	  (Figure	  1.1).	  The	  expression	  of	  bHLH	  TF	  Ascl1	  (also	  known	  as	  Mash1),	  which	  is	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dominantly	  expressed	  in	  the	  ventral	  telencephalon,	  is	  repressed	  by	  other	  bHLH	  TFs	  Ngns	   in	   the	  dorsal	   region	  (Fode	  et	  al,	  2000).	  Furthermore,	   in	   the	  cortex	  of	  the	   Ngn2KIMash1	   mice,	   miss-­‐expression	   of	   Ascl1	   up-­‐regulates	   ventral	   markers	  (Parras	  et	  al,	  2002).	  These	  studies	  strongly	  suggest	  the	  expression	  of	  Ngns	  and	  Ascl1	   are	   involved	   in	   generation	   and	   maintenance	   of	   specific	   progenitor	  populations.	   Homeodomain	   TFs	   Pax6	   and	   Gsh2	   are	   two	   critical	   factors	   in	   this	  regulatory	   network.	   Gsh2	   expression	   is	   essential	   for	   maintaining	   the	   striatal	  progenitor	   identity	   in	  vLGE.	   In	  Gsh2	  null	  mice,	  expression	  of	  ventral	  regulators	  Ascl1	  and	  Dlx	  are	  lost	  and	  the	  ectopic	  expression	  of	  dorsal	  regulators	  Pax6	  and	  Ngns	  can	  be	  found	  in	  the	  ventral	  region.	  On	  the	  other	  hand,	  Pax6	  is	  involved	  in	  maintaining	   the	   cortical	   progenitor	   identity	   in	   the	   DP.	   In	   the	   Pax6	   null	   mice,	  ectopic	   expression	   of	   Gsh2,	   Ascl1	   and	   Dlx	   is	   detected	   in	   the	   cortical	   germinal	  zone	  and	  Ngns	  are	  lost	  (Toresson	  et	  al,	  2000	  and	  Figure	  1.1).	  	  
	  
1.1.2	  Neurogenesis	  in	  mammalian	  cortex	  The	   adult	   cerebral	   cortex	   is	   segregated	   into	   6	   different	   neuronal	   layers	  (L1-­‐L6).	  Each	  cortical	  layer	  contains	  distinct	  populations	  of	  excitatory	  projection	  neurons	   (originated	   in	   the	   dorsal	   telencephalon)	   and	   inhibitory	   interneurons	  (originated	  in	  the	  ventral	  telencephalon	  and	  migrated	  into	  the	  cortex	  later).	  	  Neurogenesis	   started	   in	   the	   ventricle	   zone	   (VZ)	   of	   the	   dorsal	  telencephalon	   is	   essential	   for	   the	   formation	   of	   cortical	   layers.	   Starting	   at	   E10-­‐E11,	  neural	  progenitor	  cells	  (NPCs)	  in	  the	  VZ	  undergo	  asymmetrical	  division	  to	  generate	   one	  progenitor	   and	  one	  neuron.	  The	   first	   projection	  neurons	  migrate	  into	   the	   preplate	   (PP)	   and	   form	   the	   cortical	   plate	   (CP),	   which	   subsequently	  develops	   into	   L2-­‐L6.	   The	   additional	   CP	   neurons	   split	   the	   PP	   into	   the	  marginal	  zone	  (MZ)	  and	  the	  subplate	  (SP).	  The	  cortical	  layers	  are	  generated	  in	  an	  inside-­‐out	  manner.	  Neurons	  detained	  in	  the	  SP	  are	  generate	  first,	  followed	  by	  the	  ones	  remained	  in	  L6	  and	  L5	  (deep	  layers)	  and	  finally	  the	  upper	  layers	  (L2,	  L3	  and	  L4).	  The	  MZ	  develops	  into	  L1	  of	  the	  cortex.	  (reviewed	  in	  Guillemot,	  2005;	  reviewed	  in	  Kwan	   et	   al,	   2012;	   Figure	   1.2).	   The	   generation	   of	   GABAergtic	   interneurons	   is	  primarily	   regulated	   by	   the	   expression	   of	   proneural	   gene	   Ascl1	   in	   the	   ventral	  telencephalon	   (see	  1.2.3)	  and	   these	   inhibitory	  neurons	  migrate	   into	  all	   cortical	  layers	  in	  the	  later	  stage.	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Figure	  1.1:	  Dorsal-­Ventral	  patting	  of	  mouse	  telencephalon	  	  Embryonic	  telencephalon	  is	  divided	  into	  different	  progenitor	  domains	  along	  the	  D-­‐V	   axis.	   The	   initial	  D-­‐V	  patting	   is	   restricted	  by	   extracellular	   signalling	   events,	  including	   BMPs,	   Wnts	   and	   SHH.	   At	   E12.5,	   progenitors	   in	   the	   dorsal	   region	  express	  bHLH	  TFs	  Ngn1	  and	  Ngn2	  and	  homeobox	  genes	  Emx1,	  Emx2	  Lhx2	  and	  Pax6.	   The	   ventral	   progenitors	   express	   bHLH	   TF	  Mash1	   (also	   known	   as	   Ascl1)	  and	  homeobox	  genes	  Gsh1,	  Gsh2,	  Dlx1,	  Dlx2,	  Dlx5	  and	  Dlx6.	  Arrows	  and	  T-­‐bars	  refer	  to	  positive	  and	  negative	  controls	  	  (adapted	  from	  Schuurmans	  and	  Guillemot,	  2002)	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1.2	  bHLH	  proneural	  factors	  
1.2.1	  Identification	  of	  proneural	  genes	  Proneural	  genes	  were	  first	  discovered	  in	  Drosophila	  in	  the	  late	  1970’s.	  In	  mutant	  flies,	  a	  set	  of	  genes	  were	  identified	  that	  were	  essential	  for	  sensory	  organs	  development	  (Garcia-­‐Bellido,	  1979).	  The	  achete-­scute	  family	  members	  (achatete,	  
scute,	   lethal	   of	   scute	   and	   asense)	   and	   later	   identified	   atonal	   family	   members	  (atonal,	  amos	  and	  cato)	  share	  sequence	  similarity	  with	  each	  other	  (Gonzalez,	  et	  al,	  1989;	  Vilares	  and	  Cabrera,	  1987;	  Goulding	  et	  al	  2000	  a;	  Goulding	  et	  al	  2000	  b).	   Further	   analysis	   shows	   they	   also	   resemble	   the	   sequence	   of	   other	   genes,	  including	   the	  oncogene	  myc;	   the	   sex-­‐determination	   gene	  daughterless	   (da)	   and	  muscle-­‐determination	  gene	  MyoD,	  which	   lead	   to	   the	   identification	  of	   the	  bHLH	  DNA	  binding	  domain	  (Vilares	  and	  Cabrera,	  1987;	  Murre	  et	  al	  1989	  a;	  Murre	  et	  al	  1989	  b;	  Figure	  1.3	  A)	  The	   classification	   of	   the	   proneural	   functions	   of	   the	  achete-­scute	   and	   the	  
atonal	   families	   are	   founded	   by	   features	   shared	   by	   the	   two	   families.	   Firstly,	   in	  
Drsophila,	   proneural	   genes	   are	   expressed	   in	   ectodermal	   cells	   and	   capable	   of	  generating	  neural	   progenitors	   in	   both	  peripheral	   nerve	   system	   (PNS)	   and	  CNS	  (Campuzano	   and	   Modolell,	   1992).	   Secondly,	   proneural	   factors	   directly	   up-­‐regulate	   Notch-­‐ligands	   and	   lead	   to	   the	   activation	   of	   Notch	   signalling	   pathway,	  which	   is	   involved	   in	   balancing	   self-­‐renewing	   and	   differentiation	   of	   neuronal	  progenitors.	  In	  mutant	  flies,	  disruption	  of	  the	  Notch	  pathway	  leads	  to	  excessive	  neuronal	   differentiation	   (Artavanis-­‐Tsakonas	   et	   al,	   1995).	   In	   the	   embryonic	  telencephalon,	  Notch	  signalling	  targets	  Hes1,	  Hes5	  and	  related	  Hey	  genes	  inhibit	  the	   expression	   of	   Ascl1	   and	   Ngns	   that	   promote	   neuronal	   differentiation	  (reviewed	  in	  Pierfelice	  et	  al,	  2011).	  	  	  
1.2.2	  Biochemical	  properties	  of	  proneural	  factors	  Proneural	  proteins	  are	  basic	  helix-­‐loop-­‐helix	   (bHLH)	  TFs.	  The	  60	  amino	  acid	   long	   DNA-­‐binding	   bHLH	   motif	   is	   evolutionary	   conserved	   and	   contains	   a	  basic	   domain	   followed	   by	   two	   α-­‐helices	   that	   are	   connected	   by	   a	   flexible	   loop	  (Figure	   1.3	   B).	   The	   proneural	   bHLH	   TFs	   are	   normally	   function	   as	   homo-­‐	   or	  heterodimers,	  which	   is	  essential	   for	   its	  association	  with	  specific	  DNA	  sequence	  known	  as	  the	  E-­‐Box	  (CANNTG)	  (reviewed	  in	  Massari	  and	  Murre,	  2000).	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1.2.3	  Proneural	  factors	  in	  neural	  subtype	  specification	  	  Proneural	  bHLH	  TFs	  have	  critical	  roles	  in	  neural	  subtype	  specification.	  In	  the	   developing	  mammalian	   telencephalon,	   Ngn1,	   Ngn2	   and	  Ascl1	   are	   essential	  TFs	  involved	  in	  generating	  distinct	  progenitor	  populations:	  the	  cortex	  and	  basal	  ganglia.	   In	   the	  developing	  CNS,	  Ngns	   and	  Ascl1	   induce	  neural	   stem	  cell	   (NSCs)	  differentiation	   and	   give	   rise	   to	   mature	   neurons	   in	   a	   subtype	   specific	   manner	  (reviewed	  in	  Bertrand	  et	  al,	  2002;	  Reviewed	  in	  Ross	  et	  al,	  2003).	  	  Gain-­‐of-­‐function	   (GoF)	   studies	   have	   demonstrated	   that	   proneural	   genes	  are	   sufficient	   to	   induce	   the	   formation	   of	  mature	   neurons.	   In	   vitro	   experiments	  have	   shown	   that	   ectopic	   expression	   of	   Ascl1	   and	   Ngn2	   is	   able	   to	   induce	  autonomic	  and	  sensory	  neurogenesis	  in	  the	  dissociated	  neural	  tube	  cultures	  in	  a	  BMP2	  dependent	  manner	  (Lo,	  et	  al,	  2002).	  Furthermore,	  upon	  the	  expression	  of	  Ascl1,	  adult	  NSCs	  can	  generate	  GABAergic	  interneurons	  (Berninger	  et	  al,	  2007).	  It	  also	  has	  been	  shown	  that	  co-­‐expression	  of	  Oligo2	  and	  Ngn2	  is	  able	  to	   induce	  motor	  neurons	  in	  the	  developing	  ventral	  neuronal	  tube	  (Mizuguchi	  et	  al,	  2001)	  and	  mis-­‐expression	  of	  Ngn2	  in	  the	  ventral	  telencephalic	  progenitors	  can	  induce	  the	   formation	  of	  glutamatergic	  neurons	  (Matter	  et	  al,	  2008).	  These	  data	  clearly	  suggest	   that	   proneural	   genes	   are	   sufficient	   to	   activate	   specific	   neuronal	  differentiation	  programs.	  	  Loss-­‐of-­‐function	  (LoF)	  studies	  have	  provided	  further	  evidence	  to	  support	  that	   proneural	   factors	   are	   involved	   in	   neuronal	   identity	   specification.	   For	  example,	   in	   Ascl1	   null	   mice,	   the	   ventral	   telencephalon,	   which	   gives	   rise	   to	  GABAergic	   interneurons	   has	   several	   severe	   defects	   in	   neurogenesis,	   including	  the	   missing	   of	   MGE	   and	   the	   reduction	   of	   LGE	   in	   size	   (Guillemot	   et	   al,	   1993;	  Casarosa	  et	  al	  1999).	  These	  phenotypes	  clearly	  suggest	  that	  Ascl1	  is	  essential	  in	  the	   specification	   and/or	   maintenance	   of	   the	   ventral	   progenitor	   population.	  However,	   the	  possibility	   that	   the	  defects	  may	  due	   to	   the	   loss	  of	   the	  progenitor	  populations	   is	   undeniable.	   A	   series	   transgenic	   mouse	   models	   have	   been	  generated	   to	   assess	   the	   ability	   of	   Ascl1	   and	   Ngn2	   in	   neuronal	   subtype	  specification	   independently.	   In	   the	   transgenic	  models,	   the	  Ascl1	   (Ngn2)	   coding	  sequence	   is	   replaced	   by	   Ngn2	   (Ascl1),	   so	   the	   lost	   function	   of	   Ascl1	   (Ngn2)	   is	  
rescued	   by	   Ngn2	   (Ascl1).	   The	   mouse	   models	   are	   named	   as	   Ascl1KINng2	   and	  Ngn2KIMash1,	   respectively.	   Importantly,	   the	  proneural	   factors	   are	  not	   ectopically	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expressed	   as	   the	   endogenous	   mRNA	   levels	   are	   retained.	   In	   the	   cortex	   of	   the	  Ngn2KIMash1	   mouse,	   the	   ventral	   markers	   are	   strongly	   up-­‐regulated	   and	   a	  subpopulation	   of	   motor	   neurons	   is	   respecified	   into	   V2	   interneurons.	  Interestingly,	   Ngn2	   fails	   to	   respecify	   the	   identity	   of	   ventral	   telencephalic	  neurons,	   but	   rescues	   the	   Ascl1	   knock-­‐out	   (KO)	   phenotypes:	   normal	   MGE	  development	  and	  GABAergic	  neuronal	  specification.	  These	  experiments	  not	  only	  show	   the	   function	   of	   proneural	   genes	   in	   neural	   subtype	   specification,	   also	  indicate	   the	   difference	   in	   abilities	   between	   Ascl1	   and	   Ngn2	   in	   neuronal	   cell	  specification	  (Parras	  et	  al,	  2002).	  	  	  
1.3	  Epigenetic	  reprogramming	  Embryonic	  stem	  cells	   (ESCs)	  derived	   from	  the	   inner	  cell	  mass	  (ICM)	  are	  pluripotent	   cells	   that	   give	   rise	   to	   multiple	   differentiated	   cell	   types	   during	  mammalian	  development.	  ESCs	  isolated	  from	  ICM	  can	  be	  cultured	  in	  vitro	  while	  maintaining	   the	   ability	   to	  differentiate	   into	   all	   cell	   types	  of	   the	   embryo	  proper	  and	  self-­‐renewal	  activity	  (reviewed	  in	  Rossant,	  2008).	  These	  unique	  advantages	  have	  made	   them	   a	   powerful	   tool	   to	   understand	   early	   embryonic	   development	  and	   have	   potential	   applications	   in	   regenerative	   medicine.	   Reprogramming	   of	  somatic	  cells	  is	  capable	  to	  generate	  induced	  pluripotent	  stem	  cells	  (iPSCs),	  which	  are	   highly	   similar	   to	   ESCs	   (Wernig	   et	   al,	   2007;	   Chin	   et	   al,	   2009).	   This	   has	  attracted	  huge	  amount	  of	  attention	  because	   it	  not	  only	  provides	  easy	  access	   to	  experimental	   and	   medical	   resource,	   also	   becoming	   a	   tool	   for	   understanding	  molecular	   properties	   of	   the	   pluripotent	   stem	   cells.	   More	   recent	   studies	   using	  similar	  approach	  have	  shown	  that	  direct	  conversion	  between	  somatic	  cells	  and	  neuronal	   cells	   can	   be	   achieved	   (reviewed	   in	   Yang	   et	   al,	   2011;	   Vierbuchen	   and	  Wernig,	   2012),	   which	   has	   important	   applications	   in	   studying	   neuronal	  development	  and	  regenerative	  medicine.	  	  	  
1.3.1	  From	  somatic	  cells	  to	  pluripotent	  cells	  A	  few	  approaches	  that	  promote	  epigenetic	  reprogramming	  of	  donor	  cells	  to	  an	  embryonic	  stem	  cell	  state	  have	  been	  developed	  over	  the	  last	  decade,	  such	  as	   somatic	   cell	   nuclear	   transfer	   (Tada	   et	   al,	   2001)	   and	   fusion	   of	   somatic	   cells	  with	   ES	   cells	   (Cowan	   et	   al,	   2005).	   The	  major	   breakthrough	   in	   the	   field	   is	   the	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milestone	   strategy	   published	   by	   Takahashi	   and	   Yamanaka	   in	   2006.	   By	   forced	  expression	  of	  only	  four	  TFs:	  Oct4	  (Pou5f1),	  Sox2,	  Klf4	  and	  Myc	  (c-­‐Myc)	  (OSKM,	  also	   known	   as	   Yamanaka	   factors),	   somatic	   mammalian	   cells	   can	   be	  reprogrammed	   into	   induced	   pluripotent	   stem	   (iPS)	   cells	   (Takahashi	   and	  Yamanaka,	  2006).	  Later	  studies	  are	  showing	  that	  some	  of	  the	  original	  Yamanaka	  factors	  are	  expendable	  and	  can	  also	  be	  replaced	  by	  other	   factors.	  For	   instance,	  Klm4	   and	  Myc	   can	   be	   replaced	   by	   ESC-­‐specific	   RNA	   binding	   factor	   Lin28	   and	  homeobox	  TF	  Nango	  (Yu	  et	  al,	  2007);	  in	  the	  presence	  of	  orphan	  nuclear	  receptor	  Esrrb,	   only	   Oct4	   and	   Sox2	   are	   required	   for	   mouse	   fibroblast	   reprogramming	  (Feng	  et	  al,	  2009).	  	  However,	  one	  of	  the	  major	  disadvantages	  of	  the	  iPSC	  generation	  is	  the	  low	  efficiency.	  A	  quantitative	  reprogramming	  experiment	  that	  plate	  single	  pre-­‐B	  cells	  into	   individual	  culture	  wells	  shows	  only	  3-­‐5%	  of	  hundreds	  of	  single	  cell	  clones	  show	  pluripotency	  within	  2	  weeks	  and	  only	  a	  small	   subpopulation	  of	  daughter	  cells	  become	  fully	  reprogrammed	  (Hanna	  et	  al,	  2009).	  In	  recent	  years,	  a	  number	  of	   studies	   have	   shown	   that	   the	   reprogramming	   efficiency	   can	   be	   improved	   by	  applying	  different	  factors	  or	  small	  molecules.	  The	  active	  Wnt	  signalling	  pathway	  is	   involved	   in	   the	   maintenance	   and	   proliferation	   of	   stem	   cells	   (Willert	   et	   al,	  2003).	   As	   one	   of	   the	   downstream	   target,	   glycogen	   synthase	   kinase-­‐3	   (Gsk3)	   is	  inhibited	   by	   the	   activation	   of	   the	   Wnt	   signalling	   pathway.	   Furthermore,	  inhibition	   of	   mitogen	   activated	   protein	   kinase/Erk	   kinase	   (Mek)	   pathway	  represses	   lineage	  commitment	  and	  maintains	  self-­‐renewal	  ability	  of	  ESCs	  (Ying	  et	   al,	   2008).	   Application	   of	   Wnt3a	   ligands	   or	   PD0325901+CHIR99021	   (2i)	  (inhibitor	  of	  Mek	  and	  Gsk3	  pathways)	  significantly	  improves	  the	  reprogramming	  efficiency	   (Marson	   et	   al,	   2008;	   Silva	   et	   al,	   2008).	   Moreover,	   inhibition	   of	   the	  tumour	   suppressor	   p53	   by	   siRNA	   increases	   the	   reprogramming	   efficiency	   by	  100-­‐fold	  (Zhao	  et	  al,	  2008).	  These	  data	  indicate	  that	  a	  high	  cell	  proliferation	  rate	  is	  essential	  for	  the	  generation	  of	  iPSCs	  (Ruiz	  et	  al,	  2011).	  	  	  On	   the	   other	   hand,	   altering	   the	   epigenetic	   landscape	   also	   enhances	   the	  generation	  of	   iPSCs.	  DNA	  methyltransferases	   (Dnmts)	   are	   enzymes	   involved	   in	  the	   catalyzation	   and	   the	   maintenance	   of	   DNA	   methylation,	   which	   silence	   the	  gene	   transcription	   (reviewed	   in	   Jin	   et	   al,	   2011).	   Dnmt	   inhibitors	   5-­‐azacytidine	  (5-­‐AZA),	  RG108	  and	  Dnmt	  shRNAs	  not	  only	  enhance	  reprogramming	  efficiency	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and	  promote	  the	  full	  reprogramming	  of	  iPSCs,	  can	  also	  replace	  Sox2	  or/and	  Myc	  (Mikkelsen	   et	   al,	   2008;	   Shi	   et	   al,	   2008).	   Histone	   acetylation	   is	   another	   critical	  regulation	  mechanism	  for	  gene	  transcription,	  which	  increases	  the	  accessibility	  of	  TFs	   to	   the	   chromatin	   and	   increase	   transcriptional	   activity	   (reviewed	   in	   Struhl,	  1998).	   The	   application	   of	   histone	   deacetylase	   inhibitors	   such	   as	   valproic	   acid	  (VPA)	   also	   shows	   significant	   improvement	   in	   reprogramming	   efficiency	  (Huangfu	   et	   al,	   2008a;	   Huangfu	   et	   al,	   2008b).	   Taking	   together,	   it	   has	   become	  clear	   that	   change	   in	   epigenetic	   landscapes	   is	   essential	   for	   a	   successful	  reprogramming	  process.	  	  	  
1.3.2	  Direct	  generation	  of	  neuronal	  cells	  from	  somatic	  cells	  Direct	   conversion	   between	   two	   lineages	   was	   first	   demonstrated	   in	   the	  late	   1970’s.	   DNA	   demethylating	   agent	   5-­‐azacytidine	   is	   sufficient	   to	   induce	  myogenic,	  chondrogenic	  and	  doipogenic	  clones	  from	  an	  immortalized	  embryonic	  mouse	   fibroblast	   line	   (Taylor	   and	   Jones,	   1979).	   Following	   the	   identification	   of	  proneural	  bHLH	  factors,	  early	  studies	  have	  demonstrated	  that	  forced	  expression	  of	   Ngn1	   can	   induce	   pan-­‐neuronal	   maker	   expression	   and	   immature	   neuronal	  morphologies	  in	  chick	  embryonic	  fibroblasts	  (Perez,	  et	  al,	  1999).	  More	  recently,	  the	  Wernig	   group	   has	   shown	   that	   fibroblasts	   can	   be	   converted	   into	   functional	  neurons	   by	   overexpression	   of	   neuronal	   linage	   TFs	   (Vierbuchen	   et	   al,	   2010).	  Narrowing	  down	  from	  a	  pool	  of	  19	  genes,	  they	  identified	  a	  pool	  of	  three	  genes:	  Ascl1,	  Brn2	  and	  Myt1l	  (BAM)	  are	  sufficient	  to	  induce	  the	  generation	  of	  functional	  neurons	  (named	  as	  induced-­‐neural	  cells,	  iN	  cells).	  Surprisingly,	  the	  generation	  of	  iN	   is	   rapid	   (neuronal	  marker	   Tuj1	   can	   be	   detected	   3-­‐5	   days	   after	   induction	   of	  transgenes)	  and	  efficient	  (nearly	  20%	  in	  2	  weeks).	  iN	  cells	  have	  the	  phenotypes	  of	   glutamatergic	   neurons,	   although	   the	   expression	   of	   GABAergic	   neuronal	  markers	  GABA	  and	  GAD67	  can	  be	  detected	  at	  the	  early	  stage.	  More	   recently,	   a	   number	   of	   groups	   have	   shown	   fully	   functional	   iN	   cells	  can	  be	  generated	  from	  human	  fibroblast	  cells.	  NeuroD1	  and	  NeuroD2	  appear	  to	  be	   greatly	   involved	   in	   this	   process	   (Pang	   et	   al,	   2011;	   Yoo	   et	   al,	   2011).	  Furthermore,	  neuronal	  specific	  micor-­‐RNAs	  miR9*	  and	  miR124	  seem	  to	  be	  able	  to	   substitute	   proneural	   gene	   functions	   (Yoo	   et	   al,	   2011;	   Ambasudhan	   et	   al,	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Figure	   1.5:	   Generation	   of	   different	   cell	   lineage	   from	   fibroblasts	   using	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1.4	  Sox	  family	  TFs	  in	  cell	  fate	  specification	  Sox	   family	   members	   are	   TFs	   contain	   a	   highly	   conserved	   high-­‐mobility-­‐group	   (HMG)	   domain	   that	   was	   first	   identified	   from	   the	   mammalian	   testis-­‐determining	   factor	   Sry	   (Gubbay	   et	   al	   1990;	   Sinclair	   et	   al,	   1990).	   Generally,	  proteins	  contain	  a	  HMG	  domain	  with	  ≥50%	  identical	  in	  amino	  acids	  to	  the	  HMG	  domain	  in	  Sry	  are	  defined	  as	  Sry-­‐related	  HMG	  box	  (Sox)	  proteins.	  20	  Sox	  genes	  have	  been	  identified	  and	  they	  can	  be	  subdivided	  into	  8	  groups	  (namely	  SoxA	  to	  SoxH)	   based	   on	   the	   phylogenetic	   analysis	   of	   the	   HMG	   domains	   (reviewed	   in	  Sarkar	  and	  Hochedlinger,	  2013).	  Sox	  proteins	  within	   the	  same	  group	  share	   the	  amino	  acid	  sequence	  identify	  at	  a	  minimum	  of	  70%.	  As	  TFs,	  Sox	  proteins	  directly	  bind	   to	   the	   DNA	   in	   a	   sequence	   specific	   manner	   (core	   binding	   sequence	  (A/T)(A/T)CAA(A/T)G)	   (reviewed	   in	   Kamachi	   et	   al,	   2000;	   reviewed	   in	  Wilson	  and	  Koopman,	  2002),	  but	  with	  different	  optimal	  binding	  sequence,	  expertly.	  For	  example,	   the	   optimal	   Sox9	   binding	   sequence	   is	   AGAACAATGG	   (Mertin	   et	   al,	  1999).	  	  Over	   the	   past	   years,	   functions	   of	   the	   Sox	   family	   TFs	   have	   been	   under	  intensive	   studies	   (reviewed	   in	   Sarkar	   and	   Hochedlinger,	   2013).	   A	   number	   of	  subgroups	   of	   the	   Sox	   family	   have	   been	   shown	   to	   have	   critical	   functions	   in	  developing	  CNS.	   	   SoxB1	   (Sox1-­‐3)	  TFs	   are	   expressed	  by	  most	   of	   the	   progenitor	  cells	  in	  CNS	  and	  downregulated	  upon	  neuronal	  differentiation	  (Uwanogho	  et	  al,	  1995;	   Pevny	   et	   al,	   1998).	   Earlier	   studies	   have	   shown	   that	   SoxB1	  TFs	  maintain	  NSC	  properties	  via	  counteracting	  activities	  of	  proneural	  bHLH	  TFs	  such	  as	  Ngn2	  (Bylund	   et	   al,	   2003).	   On	   the	   other	   hand,	   Sox21	   (a	   member	   of	   the	   SoxB2	  subgroup)	   co-­‐express	   with	   Ngn2	   and	   contracting	   SoxB1	   activities,	   which	  subsequently	   promote	   neurogenesis	   (Sandberg	   et	   al,	   2005).	   Furthermore,	   the	  SoxC	   subgroup	   is	   essential	   for	   establishing	   neuronal	   properties.	   Instead	   of	  inducing	  neurogenesis	  directly,	  Sox4	  and	  Sox11	  (members	  of	  the	  SoxC	  subgroup)	  act	   downstream	   of	   proneural	   bHLH	   TFs	   and	   function	   as	   transcriptional	  activators	  of	  neuronal	  genes	  such	  as	  Tuj1	  (Bergsland	  et	  al,	  2006).	  	  The	   SoxE	   group	   contains	   three	  members:	   Sox8,	   Sox9	   and	   Sox10.	   It	   has	  been	   shown	   that	   both	   Sox9	   and	   Sox10	   are	   greatly	   involved	   in	   stem	   cell	  maintenance	   and	   specification	   in	   vertebrate	   nerve	   system.	   Sox9	   is	   involved	   in	  the	   formation	  of	  neural	   crest	   (Cheung	  and	  Briscoe,	  2003).	  Recent	  GoF	  and	  LoF	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studies	  also	  indicate	  the	  Sox9	  function	  in	  specification	  and	  maintenance	  of	  NSCs	  by	   acting	   downstream	   of	   the	   Shh	   signalling	   pathway	   in	   developing	   mouse	  telencephalon	  (Scott	  et	  al,	  2010).	  Furthermore,	  Sox9	  is	  suggested	  to	  switch	  from	  neurogenesis	  to	  gliogenesis	  in	  developing	  spinal	  cord	  (Stolt	  et	  al,	  2003).	  Sox10	  is	  expressed	   in	   neural	   crest	   stem	   cells	   (NCSCs)	   and	   is	   down-­‐regulated	   in	   NCSC	  derived	   smooth	   muscle	   cells	   and	   neurons,	   but	   remained	   in	   the	   NCSC	   derived	  Schwann	   cells	   (reviewed	   in	   Anderson	   1997).	   GoF	   studies	   suggest	   Sox10	   is	  essential	   for	   NCSCs	   maintenance	   by	   preventing	   BMP2-­‐induced	   neural	   and	  smooth	  muscle	  differentiation	  and	  TGFβ-­‐induced	  proliferative	  arrest	  (Kim	  et	  al,	  2003).	  On	  the	  other	  hand,	  Sox10	  can	  interact	  with	  Oct6	  to	  induce	  the	  expression	  of	  Krox20	  (Ghislain	  and	  Charnay,	  2006).	  The	  synergised	  expression	  of	  Sox10	  and	  Krox20	  activates	  myelin	  specific	  genes	  and	   lead	   to	   terminal	  differentiation	  and	  myelin	  formation	  of	  Schwann	  cells	  (Bondurand	  et	  al,	  2001;	  LeBlanc	  et	  al,	  2007).	  Comparing	  with	   the	   other	   two	  members	   of	   the	   group,	   the	   function	   of	   Sox8	   in	  developing	   nerve	   system	   is	   much	   less	   clear.	   Two	   studies	   indicate	   that	   Sox8	  functions	   redundantly	   with	   Sox9	   and	   Sox10	   in	   neural	   crest	   development	   in	  
Xenopus	   (O’Donnell	   et	   al,	   2006)	   and	   is	   involved	   in	   the	   oligodendrocyte	  development	  in	  a	  Sox10	  dependent	  manner	  in	  the	  spinal	  code	  (Stolt	  et	  al,	  2004).	  In	  other	  tissues,	  Sox8	  is	  shown	  to	  prevent	  MyoD-­‐mediated	  myogenesis	  (Schmidt,	  et	   al,	   2003)	   and	   negatively	   regulated	   osteoblast	   differentiation	   during	   bone	  formation	  (Schmidt	  et	  al,	  2005).	  	  
	  
1.5	  Cell	  cycle	  progression	  and	  regulation	  	  Cell	  cycle	  and	  its	  phases	  were	  first	  described	  by	  Howard	  and	  Pele	  in	  1951	  and	  it	  became	  clear	  this	  is	  a	  highly	  conserved	  and	  regulated	  process.	  A	  complete	  cell	  cycle	  can	  be	  divided	  into	  interphase	  (G1-­‐,	  S-­‐	  and	  G2-­‐phase)	  and	  mitotic	  phase	  (M-­‐phase).	  Interphase	  is	  the	  stage	  that	  a	  cell	  spends	  most	  of	  its	  time	  during	  cell	  cycle	  to	  duplicate	  cellular	  contents	  (G1-­‐phase)	  and	  chromosomes	  (S-­‐phase)	  and	  prepare	   for	   mitosis	   (G2-­‐phase).	   The	   mitotic	   phase	   (M-­‐phase)	   is	   a	   short	   stage	  comparing	   with	   the	   interphase	   and	   to	   produce	   two	   identical	   daughter	   cells	  through	  cytokinesis	  (Figure	  1.6	  A).	  During	  mitosis,	  spindles	  attach	  to	  duplicated	  chromosomes	   (prophase),	   which	   are	   aligned	   around	   metaphase	   plate	  (prometaphase	   and	   metaphase).	   The	   centromeres	   then	   divide	   and	   sister	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chromatids	   are	   pulled	   by	   spindles	   towards	   the	   opposite	   poles	   of	   the	   cells	  (anaphase).	   The	   nuclear	   member	   reforms	   around	   the	   decondensed	  chromosomes	   (telophase)	   and	   two	   daughter	   cells	   are	   formed	   after	   cytokinesis	  (Figure	  1.6	  B).	  	  Cell	  cycle	  is	  strictly	  controlled	  by	  a	  number	  of	  regulatory	  mechanisms	  that	  either	   promote	   or	   inhibit	   cell	   proliferation.	   Cyclin	   dependent	   kinases	   (Ckds),	  cyclins	   and	   Cdk	   inhibitors	   	   (CkdI)	   are	   the	   families	   provide	   primary	   regulatory	  machinery	  to	  control	  cell	  cycle	  progression.	  	  	  The	  Cdk	  family	  members	  contain	  a	  serine/threonine	  catalytic	  domain	  and	  associate	  with	  regulatrory	  partner	  cyclin,	  a	  protein	  contains	  the	  cyclin	  box	  that	  mediate	  binding	  to	  Cdk	  (Gopinathan	  et	  al,	  2011),	  to	  promote	  its	  kinase	  activity.	  	  The	   Cdk/cyclin	   complex	   drives	   cell	   cycle	   progression	   and	   promotes	   phase	  transition.	   For	   example,	   Cdk1/Cyclin	   B1	   complex	   phosphorylate	   FoxM1	   TF,	  which	   is	   essential	   for	   chromosomal	   segregation	   and	   cytokinesis,	   and	  subsequently	   drive	  M-­‐phase	   progression	   (Costa,	   2005;	   reviewed	   in	   Chen	   et	   al,	  2009).	  On	   the	  other	  hand,	  CdkI	  binds	  and	  prevents	  phosphorylation	  of	  Cdks	   to	  block	  cell	  cycle	  progression.	  Based	  on	  the	  structure	  and	  Cdk	  binding	  specificity,	  CdkI	   is	   divided	   into	   two	   families:	   the	   Ink4	   family	  members	   p16INK4a,	   p15	   INK4b,	  p18	   INK4c	   and	   p19INK4d	   primarily	   target	   Cdk4	   and	   Cdk6.	   The	   Cip/Kip	   family	  members	   p21Cip1,	   p27Kip1	   and	   p57Kip2	   are	   more	   broadly	   interfere	   with	   the	  activities	   of	   cyclin	   D-­‐,	   E-­‐,	   A-­‐	   and	   B-­‐dependent	   kinase	   complexes	   (Sherr	   and	  Roberts,	  1999).	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Chapter	  2:	  Material	  and	  method	  
	  
2.1	  Cloning	  All	   plasmids	   were	   prepared	   and	   analysed	   using	   standard	   maxiprep	  (NucleoBond	   PC500,	   Macherey-­‐Nagel,	   740574.25)	   and	   miniprep	   (GelElate	  Plasmid	   miniprep	   Kit,	   Sigma,	   PLN350-­‐1KT)	   kits	   according	   to	   manufacturer’s	  instruction.	   Restriction	   digestions	   were	   carried	   out	   according	   to	   Current	  Protocols	  in	  Molecular	  Biology	  using	  Buffer	  and	  Restriction	  Enzymes	  from	  New	  England	  Biolabs	  or	  Roche.	  Restriction	  digests	  were	  purified	  using	  QIAquick	  Gel	  extraction	  Kit	  (Qiagen,	  28706)	  according	  to	  manufacturer’s	  instruction.	  Plasmids	  were	   grown	   in	   OneShot	   Top10	   chemically	   competent	   Escherichia	   Coli	   cells	   in	  Luria	   Bertani	   (LB)	   medium	   or	   LB/Agar	   plates	   (for	   single	   colony	   isolation)	  containing	  100mg/ml	  ampicillin	  (Sigma).	  	  	  
2.2	  Generation	  of	  short	  hairpin	  (sh)RNA	  containing	  plasmids	  Oligonucleotides	  for	  shRNA	  were	  designed	  by	  online	  tool	  Whitehead	  RNAi	  (http://sirna.wi.mit.edu)	   or	   ordered	   based	   on	   published	   data	   (see	   2.9.1	   for	  sequences	  of	  oligonucleotides).	  	  Oligonucleotides	  were	   ordered	   from	   Sigma	   and	   dissolved	   in	  water	  with	  the	   concentration	   of	   100μM	   (100pmol/μl).	   Each	   hybridization	   reaction	  contained	  800pmol	  of	   forward	  and	  reverse	  shRNA	  oligonucleotides,	  2μl	  of	  10X	  NEB3	   buffer	   and	   2μl	   of	   water.	   Sample	   was	   heated	   at	   95C°	   for	   5	   minutes	   and	  allowed	  to	  cool	  down	  to	  room	  temperature	  in	  the	  heat	  block.	  	  P-­‐Super-­‐Puro	  and	  P-­‐Super-­‐neo-­‐GFP	  vectors	  were	  digested	  with	  BglII	  and	  XhoI	   restriction	   enzymes	   and	   purified	   by	   gel	   extraction	   kit	   according	   to	  manufacturer’s	   instruction.	   Hybridized	   shRNA	   was	   ligated	   with	   the	   digested	  vector	  using	  T4	  DNA	   ligase	   and	  buffer	   (P-­‐Super-­‐Puro-­‐shRNA	  and	  P-­‐Super-­‐neo-­‐GFP-­‐shRNA).	   The	   correction	   insertion	   was	   confirmed	   by	   sequencing	  (Sourcebioscience).	  	  P-­‐Super-­‐Puro-­‐shRNA	  and	  p-­‐Ad5-­‐GFP	  lentiviral	  vector	  were	  digested	  with	  XhoI	   and	   EcoRI	   restriction	   enzymes.	   The	   350bp	   fragment	   from	   P-­‐Super-­‐Puro-­‐shRNA	  that	  contained	  the	  shRNA	  was	  ligated	  with	  digested	  p-­‐Ad5-­‐GFP	  lentiviral	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vector	   using	   T4	   DNA	   ligase	   and	   buffer	   (p-­‐Ad5-­‐shRNA-­‐GFP).	   The	   correction	  insertion	  was	  confirmed	  by	  sequencing.	  	  	  
2.3	  Production	  of	  lentivirus	  Lentiviruses	   were	   produced	   from	   HEK293T	   cells.	   Lipofectamine	   2000	  (Invitrogen,	  11668-­‐019)	  was	  used	  for	  cell	  transfection.	  	  	  3	  million	  HEK293T	  cells	  were	  seeded	  in	  10cm	  cell	  culture	  dish	  the	  night	  before	   the	   transfection.	   For	   each	   transfection	   reaction,	   12μg	   of	   lentiviral	  plasmids,	   9μg	   of	   psPax2	   lentiviral	   packaging	   plasmids	   and	   3μg	   of	   VSV-­‐G	  pseudotyping	   plasmids	   were	   mixed	   with	   1.5ml	   opti-­‐MEM	   medium;	   60μl	   of	  Lipofectamine	  2000	  reagent	  was	  gently	  mixed	  with	  1.5ml	  opti-­‐MEM	  medium	  and	  incubated	   at	   room	   temperature	   for	   5	   minutes.	   The	   plasmids	   mixture	   and	  Lipofectamine	   2000	   mixture	   were	   gently	   mixed	   and	   incubated	   at	   room	  temperature	   for	   20	   minutes;	   HEK293T	   cells	   were	   carefully	   washed	   with	   PBS	  before	  the	  transfection	  reagent	  was	  applied	  and	  incubated	  at	  37C°	  for	  4.5	  hours;	  the	   transfection	   reagent	   was	   then	   replaced	   with	   pre-­‐warmed	   HEK-­‐293T	  medium.	  	  The	  supernatant	  was	  collected	  at	  24h	  and	  48h.	  Lentiviral	  particles	  were	  concentrated	   from	   the	   supernatant	   by	   ultra-­‐centrifugation	   at	   20,000rpm	   for	   2	  hours.	  The	  viral	  pellet	  was	  resuspended	  in	  PBS	  and	  stored	  at	  -­‐80C°.	  	  
2.4	  RNA	  isolation	  and	  cDNA	  synthesis	  Cells	   for	   total	   RNA	   isolation	   were	   prepared	   in	   6-­‐well	   plate.	   Growth	  medium	  was	  removed	  from	  the	  well	  and	  1ml	  TRIzol	  reagent	  (Invitrogen,	  15596-­‐026)	  was	   added	  directly	   to	   the	   cells.	   The	   cells	  were	   lysed	  by	  pipetting	   up	   and	  down	  several	  times	  and	  collected	  in	  the	  1.5ml	  eppendorf	  tube.	  	  The	  homogenized	  sample	  was	  incubated	  at	  room	  temperature	  for	  5	  minutes.	  200μl	  of	  chloroform	  was	   added	   and	   the	   sample	   was	   shaken	   vigorously	   for	   15	   seconds	   before	  incubated	   at	   room	   temperature	   for	   2	   minutes.	   Phases	   were	   separated	   by	  centrifugation	  at	  12,000g	   for	  15	  minutes	  at	  4C°.	  The	  aqueous	  upper	  phase	  was	  carefully	  transferred	  into	  a	  new	  tube	  and	  500μl	  of	  100%	  isopropanol	  was	  added	  for	   RNA	   precipitation.	   The	   sample	   was	   mixed	   and	   incubated	   at	   room	  temperature	  for	  10	  minutes.	  The	  sample	  was	  then	  centrifuged	  at	  12,000g	  for	  10	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minutes	   at	   4C°	   and	   the	   RNA	   pellet	   was	   washed	   with	   1ml	   75%	   ethanol	   and	  subsequently	   centrifuged	   at	   12,000g	   for	   5	  minutes	   at	   4C°.	   The	   pellet	   was	   air-­‐dried	  and	  dissolved	   in	  50μl	  of	  RNase	   free	  water.	  The	  concentration	  of	   the	  RNA	  was	  checked	  by	  a	  spectrophotometer.	  For	  expression	  microarray	  analysis,	  RNA	  clearup	  was	  performed	  using	  RNaEase	  Mini	  Kit	   (QINGEN,	   76104)	   according	   to	  the	  manufacturer’s	  instruction.	  	  cDNA	  was	  synthesised	  using	  the	  High	  Capacity	  RNA-­‐to-­‐cDNA	  master	  mix	  (Applied	  Biosystem,	  4390781).	  For	  each	  20μl	  of	  reverse	  transcriptase-­‐PCR	  (RT-­‐PCR)	   reaction,	   400ng	   of	   total	   RNA	   and	   4μl	   of	   RNA-­‐to-­‐cDNA	  master	   mix	   were	  used.	   The	   reaction	  was	   incubated	   at	   25C°	   for	   5	  minutes	   and	   then	   42C°	   for	   30	  minutes.	  The	  reaction	  was	  stopped	  by	  heating	  to	  85C°	  for	  5	  minutes	  and	  hold	  at	  4C°.	  The	  cDNA	  product	  was	  diluted	  12	  times	  for	  further	  use.	  	  
2.5	  Quantitative	  real	  time	  PCR	  Quantitative	   Real	   time	   PCR	   (q-­‐PCR)	   was	   performed	   according	   to	   the	  manufacturer’s	  instruction	  using	  iTaq	  SYBR	  Green	  supermix	  with	  Rox	  (Bio-­‐Rad,	  172-­‐5853)	  on	  an	  ABI7900	  machine	  (Applied	  Biosystem).	  For	  each	  16μl	  reaction,	  8μl	  of	  SYBR	  Green	  supermix,	  3μl	  of	  water,	  1μl	  of	  primer	  mix	  (180μl	  water	  mixed	  with	  10μl	  of	  forward	  and	  10μl	  reverse	  primers,	  (see	  2.9.1	  for	  primer	  sequences)	  and	  4μl	  of	  cDNA	  template	  (see	  2.4	  for	  cDNA	  synthesis).	  The	  housekeeping	  genes	  Tbp	   and	   Hprt	   were	   used	   for	   normalization.	   The	   relative	   expression	   was	  calculated	   as	   E	   =	   2-­‐ΔCt,	   where	   ΔCt	   =	   CtGene	   Analysed	   -­‐	   CtHousekeeping	   Gene	   (Ct:	   mean	  threshold	  of	  cycle	  number).	  	  	  
2.6	  Expression	  microarray	  analysis	  For	  microarray	   analysis,	   the	   concentration	   and	   quality	   of	   the	   total	   RNA	  was	  assessed	  by	  spectrophotometry	  (RNA	  sample	  requirement:	  minimum	  60ng	  of	   RNA	   after	   RNA	   cleanup;	   the	   260/230	   ratio	   ≥1.8).	   All	   RNA	   samples	   were	  diluted	  to	  30ng/μl	  and	  processed	  according	  to	  the	  IIIumina	  Whole-­‐Genome	  Gene	  Expression	   Direct	   Hybridization	   Assay	   Guild	   using	   IIIumina®	   TotalPrep™-­‐96	  RNA	  Amplification	  Kit.	  Samples	  were	  hybridized	  to	  a	  Mouse	  Ref-­‐8	  v2	  arrays	  and	  scanned	  by	  the	  BeadArray	  Reader.	  The	  array	  intensity	  data	  was	  loaded	  into	  the	  IIIumina	  BeadStudio	  software	  and	  normalized	  with	  the	  background.	  All	  analysis	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was	  performed	  on	  biological	  triplicates.	  The	  significant	  analysis	  was	  performed	  by	   GeneSpring	   software	   and	   using	   one-­‐way-­‐ANOVA	   with	   subsequent	   p-­‐value	  correction	  by	  Benjamini-­‐Hochberg	  post-­‐hoc	  correction.	  	  For	  MEFs	  Ascl1	  GoF	  array,	  significantly	  de-­‐regulated	  probes	  were	  defined	  as	  probes	  with	  a	  corrected	  p-­‐value	  ≤0.05	  and	  a	   fold	  change	  ≥2	  related	   to	  eGFP	  viral	  infected	  cells	  at	  same	  time	  point.	  For	  NS5	  SoxE	  LoF	  array,	  significantly	  de-­‐regulated	  probes	  were	  defined	  as	  probes	  with	  a	   corrected	  p-­‐value	  ≤0.05	  and	  a	  fold	  change	  ≥1.5	  related	  Con	  shRNA	  transfected	  cells	  at	  the	  same	  time	  point.	  	  
	  
2.7	  in	  vitro	  cell	  culture	  
2.7.1	  P19	  and	  human	  embryonic	  kidney	  (HEK)	  293T	  cell	  culture	  P19	   embryonic	   carcinoma	   cells	   HEK293T	   cells	   were	   cultured	   in	  Dulbecco’s	  Modified	  Eagle’s	  Medium	  (DMEM,	  Sigma,	  D5671)	  supplemented	  with	  10%	   fetal	   calf	   serum	   (FBS,	  Hyclone),	   50IU	  Penicilin/Streptomycin	   (Invitrogen)	  and	  2mM	  L-­‐Glutamine	  (Invitrogen).	  	  	  
2.7.2	  NS5	  cell	  culture	  	  NS5	   cells	   were	   cultured	   in	   EUROMED-­‐N	   medium	   (EURO-­‐LONE,	  ECM0883L)	  supplemented	  with	  50IU	  Penicilin/Streptomycin	  (Invitrogen),	  2mM	  L-­‐Glutamine	  (Invitrogen),	  N2-­‐supplement	  (R&D,	  AR009),	  Bovine	  Serum	  Albumin	  (BSA),	  EGF	  (peprotech,	  315-­‐09,	  10ng/ml),	  FGF-­‐2	  (peprotech,	  450-­‐33,	  10ng/ml)	  and	  Laminin	  (sigma,	  L2020,	  20ug/ml).	  	  	  
2.7.3	  Mouse	  embryonic	  fibroblasts	  (MEFs)	  isolation	  and	  culture	  	  MEFs	  were	  isolated	  from	  E14-­‐E14.5	  wild-­‐type	  Parkes	  mice	  embryos.	  The	  head,	  vertebral	  column,	  dorsal	  root	  ganglia	  and	  all	  internal	  organs	  were	  carefully	  removed	   and	   discarded.	   The	   remaining	   tissues	   were	   dissociated	   with	   0.25%	  trypsin	  (Sigma)	  at	  37C°	   for	  10-­‐15	  minutes	   to	  create	  single	  cell	  suspension.	  The	  cells	   were	   cultured	   in	   T150	   tissue	   culture	   flask	   in	   MEF	   medium	   [DMEM	  supplemented	   with	   10%	   FES,	   non-­‐essential	   amino	   acid	   (Invitrogen),	   sodium	  pyruvate	  (Invitrogen)	  and	  50IU	  Penicilin/Streptomycin]	  at	  37C°	  until	  confluent.	  The	  cells	  were	  frozen	  and	  stored	  in	  liquid	  nitrogen.	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2.7.4	  Direct	  reprogramming	  of	  MEF	  to	  neurons	  Lentiviral	   plasmids	   Tet-­‐O-­‐FUW-­‐Ascl1,	   Tet-­‐O-­‐FUW-­‐Brn2	   and	   Tet-­‐O-­‐FUW-­‐Myt1l	  were	  kindly	  provided	  by	  Dr	  Vania	  Broccoli,	   San	  Raffaele	   Institute,	  Milan,	  Italy.	  Tet-­‐O-­‐FUW-­‐eGFP	  plasmid	  was	  purchased	  from	  addgene	  (addgene	  plasmid	  30130).	   Tet-­‐O-­‐FUW	   empty	   plasmid	   was	   generated	   from	   Tet-­‐O-­‐FUW-­‐eGFP	   by	  EcoRI	   restriction	   enzyme	   digestion.	   The	   expression	   of	   the	   transgenes	   was	  doxycycline	  inducible	  (Figure	  3.1	  B-­‐E).	  	  Protocol	  for	  direct	  reprogramming	  of	  MEF	  into	  neurons	  by	  transcriptional	  factors	   (Ascl1,	   Brn2	   and	   Myt1l)	   was	   established	   by	   Marius	   Wernig	   group	  (Vierbuchen	   et	   al,	   2010).	   Briefly,	   Ascl1,	   Brn2	   and	   Myt1l	   transgenes	   were	  delivered	  to	  cultured	  MEFs	  (see	  2.7.2	  for	  MEFs	  isolation)	  by	   lentiviral	   infection	  (see	   2.3	   for	   production	   of	   lentiviruses).	   The	   expression	   of	   the	   reprogramming	  factors	   was	   induced	   by	   the	   application	   of	   doxycycline.	   Ascl1,	   Brn2	   and	   Myt1l	  lentiviruses	   or	   Ascl1	   lentiviruses	   were	   added	   to	   passage	   3	   MEFs,	   which	   were	  seeded	  the	  night	  before	   the	   infection	  (60,000/well	   for	  24-­‐well	  plate).	  The	   total	  amount	   of	   viruses	   added	   into	   each	   condition	   remained	   the	   same	   by	   adding	  viruses	  carrying	  empty	  lentiviral	  vector.	  After	  20-­‐24	  hours	  in	  medium	  containing	  lentivirus,	   the	   cells	   were	   switch	   to	   fresh	   MEF	  medium	   containing	   doxycycline	  (2μg/ml).	   48	   hours	   later,	   the	   culture	   medium	   was	   switched	   to	   N3	   medium	  [DMEM/F12	   (Invitrogen)	   containing	   insulin	   (25μg/ml,	   Sigma),	   transferrin	  (50μg/ml,	  Sigma),	  sodium	  selenite	  (30nM,	  Sigma),	  progesterone	  (20nM,	  Sigma),	  putrescine	   (100nM,	   Sigma)	   and	   Penicilin/Streptomycin	   (50IU,	   Simga)]	  containing	   doxycycline	   (Sigma).	   The	   N3	  medium	  was	   changed	   every	   2-­‐3	   days.	  Reprogrammed	  MEFs	  were	  fixed	  at	  D-­‐7,	  D-­‐13	  and	  D-­‐22	  for	  analysis.	  	  	  
2.8	  Immunocytochemistry	  and	  image	  analysis	  For	   in	   vitro	   immunostaining,	   cells	   were	   cultured	   on	   glass	   coverslips	  (Fisher	   Scientific).	   Cells	   were	   fixed	   with	   4%	   paraformaldehyde	   (PFA)	   in	  phosphate	  buffered	  saline	  (PBS)	  containing	  15%	  sucrose	  for	  25	  minutes	  at	  room	  temperature.	  The	  cells	  were	  then	  permeabilized	  with	  0.5%	  Triton	  (Sigma)	  for	  8	  minutes	   and	   blocked	   with	   10%	   FBS.	   Incubation	   with	   primary	   and	   secondary	  antibody	  was	  performed	  at	  room	  temperature	  for	  1.5	  hours	  and	  45	  minutes	  	  (see	  2.9.2	  for	  antibody	  used	  in	  experiments)	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Immunofluorescence	  images	  were	  captured	  using	  a	  ProgRes	  C14	  camera	  (Jenoptik)	   linked	   to	  an	  Axioplan	   II	  microscope	  (Zeiss)	  under	   the	  20X	  objective.	  For	   MEF	   reprogramming	   experiments,	   10	   images	   were	   randomly	   taken	   for	  individual	   culture	   conditions.	   	   Images	   were	   processed	   and	   analysed	   with	  Openlab	  (Perkin	  Elmer)	  and	  Fiji	  (NIH).	  	  
2.9	  Western	  blot	  Immunoblots	  were	  done	  following	  the	  standard	  protocol.	  Equal	  amount	  of	  protein	   were	   separated	   on	   a	   10%	   SDS-­‐PAGE	   and	   blotted	   into	   nitrocellulose	  membranes	   (BioRad).	   Antibodies	   against	   Sox9,	   V5	   and	   actin	   (loading	   control)	  were	  used	  to	  detection	  (see	  234	  for	  antibody	  dilution).	  For	  secondary	  antibodies,	  horseradish	  peroxidase	  (HRP)-­‐linked	  anti-­‐mouse/rabbit	  antibodies	  were	  used	  at	  a	  1:2000	  dilution.	  	  	  
2.10	  Fluorescence-­activated	  cell	  sorting	  (FACS)	  analysis	  Cultured	   cells	   were	   collected	   and	   resuspended	   in	   ice	   cold	   70%	   EtOH.	  Samples	  were	  immediately	  put	  on	  ice	  then	  transferred	  to	  -­‐20	  C°	  for	  2h.	  	  Cells	   were	   resuspended	   in	   0.5ml	   PBS	   supplemented	   with	   RNAseA	  (0.1mg/ml)	  and	  Propidium	  iodide	  (sigma,	  40ng/ml).	  Samples	  were	  incubated	  at	  37	  C°	  for	  1h	  and	  kept	  on	  ice	  until	  analyse.	  
	  
2.11	  Materials	  
2.11.1	  Oligonucleotides	  2.11.1.1.	  Cloning	  Aof1	  shRNA1	  FW:	  TCGAGAAAAAGGCGAGGCCTATGATATTATCTCTTGAATAATATCATAGGCCTCGCCGGG	  Aof1	  shRNA2	  FW:	  TCGAGAAAAAGGTACTGATAAGGGAAGTATCTCTTGAATACTTCCCTTATCAGTACCGGG	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Cbfa2t3	  shRNA1	  FW:	  GATCCCCGCGTCTCTGTCTTTGTAAATTCAAGAGATTTACAAAGACAGAGACGCTTTTTTC	  Cbfa2t3	  shRNA2	  FW:	  GATCCCCGTGGCGATCAGGTTAATTATTCAAGAGATAATTAACCTGATCGCCACTTTTTC	  	  Sox8	  shRNA	  FW:	  GATCCCCGCAGCGAGGTTATCAGTAATTCAAGAGATTACTGATAACCTCGCTGCTTTTTC	  Sox9	  shRNA	  FW:	  GATCCCCGTGTGTTGTTATAGTAACATTCAAGAGATGTTACTATAACAACACACTTTTTC	  Zfp238	  shRNA1	  FW:	  GATCCCCGCTTCATGCAGCATGTATTTCTTCAAGAGAGAAATACATGCTGCATGAAGCTTTTTC	  Zfp238	  shRNA2	  FW:	  GATCCCCGGGTATCAGACGTGTTACATTCAAGAGATGTAACACGTCTGATACCCTTTTTC	  	  2.11.1.2	  gene	  expression	  analysis	  Aof1:	  AGATGGAGCCCTCCAAGG(FW)	  	  GCACTTCTGAGGGGTGAGAG(RV)	  Ascl1	  endo:	  TCTCCTGGGAATGGACTTTG(FW)	  	  GGTTGGCTGTCTGGTTTGTT(RV)	  Ascl1	  ORF:	  CGTCCTCTCCGGAACTGAT(FW)	  	  CTGCTGTGGCAGGCTGTAG(RV)	  Cbfa2t3:	  ACCCTCCTTCACACCTCACA(FW)	  	  GCTGAAGCCATTGGGTGTA(RV)	  Dpysl4:	  GACCCCAGCTGATGATTTCT(FW)	  	  ACCAGCGTCAGGAAACACAT(RV)	  Fjx1:	  GCTTGTGAGCAACCTCTTCA(FW)	  	  TCGGAATACACACACCGACT(RV)	  Hapb4:	  CCTGGGGATCAGGTAAAGAC	  (FW)	  	  GTGCAGGTGGCTCTGTATCA	  (RV)	  Hes6:	  ACCCACCTCGCTGAGTAGTT(FW)	  	  CCTGAAGACTCTCGTTGATCC(RV)	  Hprt:	  AGCCTAAGATGAGCGCAAGT	  (FW)	  	  ATGGCCACAGGACTAGAACA(RV)	  Id2:	  CAGAGACCTGGACAGAACCA	  (FW)	  	  TCAGAAGGGAATTCAGATGC	  (RV)	  Jmjd2c:	  CAGCAGGTAGCGAGTGATGA(FW)	  	  TGCTGTCTCCCATCTAGAATCA(RV)	  Mfng:	  TCGTGGTCACCAACTGTTCT(FW)	  	  GCCTTGGGGTTCACATAGTT(RV)	  Nav1:	  TCTACAGGAAGGAGCCAAGG(FW)	  GTCTTCCCAAGCAGCTTTCT(RV)	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Ncoa1:	  GGAACCTTTTCACCCAACAT	  (FW)	  	  TGCAAACTGGTTCAAGATGG	  (RV)	  Nes:	  GAGGTGACCCTTGGGTTAGA	  (FW)	  	  TAGCCCTACCACTTCCTGCT(RV)	  	  Plekhg5:	  GAGCTACCCTCCCCAGACTC(FW)	  	  TGTGGAACTTGCTATCACAGG(RV)	  Sema6b:	  GACACTGTTCATTGGGGACA(FW)	  	  GATGTCACTGGGGTTGGAG(RV)	  Sox8:	  GTACCCGCATCTCCATAACG	  (FW)	  	  GGCCCAGTTCAGTACCAGAG(RV)	  Sox9:	  AGAACAAGCCACACGTCAAG(FW)	  	  TCCACGAAGGGTCTCTTCTC(RV)	  Sox10:	  CAGCAAGACACTAGGCAAGC(FW)	  	  CTTGTAGTCCGGATGGTCCT(RV)	  Tbp:	  GGGGAGCTGTGATGTGAAGT(FW)	  	  CCAGGAAATAATTCTGGCTCA(RV)	  Zfhx1a:	  AAGAACTGCTGGCAAGACAA(FW)	  	  GCTGCAGAAATTCTTCCACA(RV)	  Zfp238:	  GATGGTCCCCAGTGAGAGAA(FW)	  	  GACAGTCCCAGTGACCCAGT(RV)	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Chapter	  3:	  Functions	  of	  Sox8	  in	  direct	  conversion	  of	  
mouse	  embryonic	  fibroblasts	  to	  neurons	  
	  
3.1	  Rational,	  hypothesis	  and	  aim	  	  Ascl1	   (also	   known	   as	   Mash1)	   is	   a	   basic-­‐Helix-­‐Loop-­‐Helix	   (bHLH)	  transcriptional	   factor	   (TF),	   which	   has	   critical	   functions	   in	   neuronal	  differentiation	   and	   cell	   type	   specification	   during	   central	   nerve	   system	   (CNS)	  development.	   Ascl1	   is	   primarily	   expressed	   at	   the	   ventral	   region	   of	   developing	  telencephalon	  in	  mouse	  (Fode	  et	  al,	  2000),	  which	  is	  the	  birthplace	  of	  GABAergic	  neurons	   (Parras	   et	   al,	   2006).	   Here,	   neural	   stem	   cells	   expressing	   Ascl1	   are	  withdrawn	   from	  cell	   cycle	  and	  committed	   to	  neuronal	  differentiation.	  Genome-­‐wide	  studies	  using	  ChIP-­‐on-­‐Chip	  arrays	  have	  identified	  Ascl1-­‐binding	  sites	  in	  the	  proximal	  promoter	  regions,	  which	  suggest	  that	  Ascl1	  regulates	  genes	  involved	  in	  all	  major	  steps	  of	  neurogenesis	  in	  a	  direct	  manner	  (Castro	  et	  al,	  2010).	  	  In	   2010,	   Wernig	   and	   associates	   established	   the	   protocol	   to	   directly	  convert	  fibroblasts	  into	  functional	  neurons	  by	  overexpression	  of	  neurogenic	  TFs:	  Ascl1,	  Brn2	  and	  Myt1l	   (Vierbuchen	  et	  al,	  2010).	  Ascl1	   is	   the	  essential	   factor	   to	  ensure	   the	   efficient	   reprogramming	   process.	   Using	   the	   similar	   approach,	   a	  number	  of	  groups	  using	  different	  TF	  recipes	  have	  reprogrammed	  mouse	  or/and	  human	  fibroblasts	  into	  functional	  neurons	  (reviewed	  in	  Vierbuchen	  and	  Wernig,	  2012).	   Ascl1	   is	   the	   critical	   factor	   involved	   in	   the	   majority	   of	   the	   recipes.	  Furthermore,	   ectopic	   expression	   of	   Ascl1	   alone	   is	   sufficient	   to	   induce	   the	  generation	  of	  immature	  neurons	  (Figure	  3.1	  D	  and	  1D’;	  Vierbuchen	  et	  al,	  2010).	  These	   suggest	   that	   Ascl1	   has	   critical	   functions	   in	   the	   direct	   reprogramming	  mechanisms.	  	  As	  Ascl1	  is	  an	  essential	  factor	  to	  activate	  neuronal	  specific	  programme	  in	  both	   neuronal	   differentiation	   and	   direct	   reprogramming,	   we	   hypothesise	   that	  identifying	  common	  Ascl1	  downstream	  genes	  allows	  us	  to	  understand	  molecular	  mechanisms	  in	  both	  programmes.	  Here,	   I	   used	   Ascl1	   Gain	   of	   Function	   (GoF)	   approach	   to	   identify	   Ascl1	  downstream	   genes	   at	   the	   early	   stage	   of	   MEFs	   reprogramming	   and	   further	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investigated	   functions	  of	  Sox8	   in	  Ascl1-­‐mediated	  reprogramming	  process	  using	  both	  GoF	  and	  Loss	  of	  Function	  (LoF)	  studies.	  	  	  
3.2	  Re-­establishment	  of	  MEFs	  reprogramming	  in	  vitro	  In	   order	   to	   identify	   downstream	   factors	   contributing	   to	   Ascl1-­‐mediated	  reprogramming,	   it	   was	   essential	   to	   demonstrate	   the	   in	   vitro	   reprogramming	  system	   could	   be	   re-­‐established.	   To	   reproduce	   the	   direct	   reprogramming	  experiment,	   I	   followed	   the	   protocol	   established	   by	   the	   Wernig	   group	  (Vierbuchen	   et	   al,	   2010).	   Briefly,	   lentiviruses	   carrying	   Ascl1,	   Brn2	   and	   Myt1l	  transgene	  were	  used	  to	  infect	  passage	  3	  MEFs	  isolated	  from	  E14-­‐E14.5	  wild-­‐type	  Parkes	   mouse	   embryos.	   The	   expression	   of	   the	   transgene	   was	   doxycycline	  dependent.	   Induced	   neurons	   (iNs)	   were	   identified	   by	   immunocytochemistry	  using	  antibody	  against	  neuronal	  class	  III	  β-­‐tubulin	  (Tuj1)	  (Figure	  3.1	  A	  and	  B).	  In	  addition	   to	   the	   three-­‐TF	   condition	   (Ascl1+Brn2+Myt1l;	   BAM	   condition),	   I	   also	  used	  Ascl1	   alone	   to	   reprogram	  MEFs	   for	   two	   reasons.	   Firstly,	   previous	   studies	  have	   shown	   that	   Ascl1	   is	   sufficient	   to	   induce	   immature	   neuronal	   features	  (Vierbuchen	   et	   al,	   2010),	   which	   suggests	   that	   Ascl1	   is	   sufficient	   to	   activate	  neuronal	  specific	  program	  during	  direct	  reprogramming	  of	  fibroblasts.	  Secondly,	  I	  was	  focusing	  on	  the	  functions	  of	  Ascl1	  during	  the	  reprogramming	  process	  and	  the	  additional	  expression	  of	  Brn2	  and	  Myt1l	  might	  interfere	  the	  identification	  of	  Ascl1	  downstream	  genes.	  	  	  	  At	  day	  7,	  Tuj1-­‐positive	  cells	  were	  detected	  in	  both	  BAM	  (Figure	  3.1	  C)	  and	  Ascl1	   alone	   (Figure	   3.1	   D)	   conditions.	   To	   compare	   the	   morphology	   of	   the	  reprogrammed	   cells,	   it	   was	   clear	   that	   cells	   reprogrammed	   under	   the	   BAM	  condition	   had	   a	   more	   mature	   neuronal	   phenotype	   (cells	   had	   bipolar	   or	  multipolar	   structure	   and	   long	   extended	   processes;	   Figure	   3.1	   C	   and	   D).	   The	  observation	  was	   also	   confirmed	   by	   the	   quantification.	   Tuj1-­‐positive	   cells	  were	  divided	   into	   2	   populations:	   one	  with	   processes	   longer	   than	   3	   cell	   body	   length	  (mature	   neurons,	   which	  was	   defined	   as	   iN)	   and	   the	   other	   one	  with	   processes	  shorter	   than	   3	   cell	   body	   length	   (immature	   neurons).	   70%	  of	   the	   Tuj1-­‐positive	  cells	   could	  be	  defined	  as	   iN	  under	   the	  BAM	  condition	  and	  only	  12.5%	  of	  Tuj1-­‐positive	  cells	  under	  Ascl1	  only	  condition	  could	  be	  classified	  as	  iN	  (Figure	  3.1	  E).	  The	  reprogramming	  efficiency	  (calculated	  using	  only	  the	  number	  of	  iN)	  was	  15%	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under	   the	   BAM	   condition	   and	   5%	   using	   Ascl1	   alone	   (Figure	   3.1	   E’).	   Similar	  results	  were	  observed	  at	  day	  13	  cultures	  (Figure	  3.1	  C’	  and	  D’).	  Under	  the	  BAM	  and	  Ascl1	  only	  conditions,	  90%	  and	  15%	  of	  Tuj1-­‐positive	  cells	  could	  be	  defined	  as	  iN	  and	  the	  reprogramming	  efficiency	  was	  12%	  and	  6%	  (Figure	  3.1	  F	  and	  F’).	  In	   conclusion,	   we	   have	   successfully	   re-­‐established	   the	   in	   vitro	  reprogramming	  system	  by	  converting	  MEFs	  into	  neurons.	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3.3	   Identification	  of	  Ascl1	  downstream	  genes	  at	   the	  early	  stage	  
of	  MEF	  reprogramming	  To	  assess	  whether	  common	  regulatory	  mechanisms	  were	  involved	  in	  both	  Ascl1-­‐mediated	  MEFs	  reprogramming	  and	  neuronal	  differentiation,	  I	  decided	  to	  perform	   genome-­‐wide	   expression	   microarrays	   to	   detect	   gene	   expression	  changes	   at	   the	   early	   stage	   of	   MEFs	   reprogramming	   under	   GoF	   condition.	   As	  shown	  in	  earlier	  experiments,	  Ascl1	  alone	  is	  sufficient	  to	  induce	  the	  activation	  of	  neuronal	   specific	   programs	   (Figure	   3.1	   D	   and	   E).	   Furthermore,	   I	   aimed	   to	  identify	  Ascl1	  downstream	  genes	   and	  additional	   expression	  of	  Brn2	  and	  Myt1l	  would	   interfere	   the	   experiment.	   For	   these	   reasons,	   the	   gene	   expression	  microarrays	  were	  performed	  under	  Ascl1	  GoF	  condition.	  Two	  experiments	  were	  performed	   for	   mRNA	   sample	   collection	   (Figure	   3.2	   A).	   Experiment	   A:	  lentiviruses	  carrying	  Ascl1	  transgene	  and	  doxycycline	  were	  added	  into	  P3	  MEFs	  cultures	   at	   the	   same	   time.	   RNA	   samples	   were	   collected	   at	   12h	   	   (A1)	   and	   24h	  (A2).	   Experiment	   B:	   doxycycline	   was	   added	   into	   the	   cell	   culture	   24h	   post	  infection.	  RNA	  samples	  were	  collected	  at	  12h	  (B1)	  and	  24h	  (B2).	  Samples	  were	  collected	  from	  three	  independent	  biological	  replicates.	  Delta-­‐like	  3	  (Dll3)	  has	  been	  shown	  to	  be	  a	  direct	  target	  of	  Ascl1	  and	  was	  used	  as	  a	  read-­‐out	  for	  Ascl1	  function	  in	  our	  in	  vitro	  system	  (Castro	  et	  al,	  2006).	  The	  expression	  of	  Dll3	  and	  Ascl1	  was	  analysed	  by	  quantitative	  RT-­‐PCR	  (qPCR)	  as	  quality	   control	   of	   the	   mRNA	   samples.	   Compared	   to	   eGFP	   infected	   control	  samples,	  significant	  up	  regulation	  of	  Ascl1	  expression	  was	  observed	  (A1,	  A2,	  B1	  and	  B2).	  Dll3	  expression	  was	  up	  regulated	   in	  A2,	  B1	  and	  B2.	   	  Furthermore,	   the	  expression	  level	  of	  Ascl1	  and	  Dll3	  were	  had	  minor	  differences	  between	  biological	  replicates	  (Figure	  3.2	  B).	  Nevertheless,	  addition	  of	  doxycycline	  led	  to	  an	  increase	  in	  Ascl1	  mRNA	  expression	  and	  up	  regulation	  of	  early	  Ascl1	  target	  Dll3	  suggested	  Ascl1	  GoF	  was	  sufficient	  to	  deregulate	  downstream	  genes	  in	  our	  in	  vitro	  system.	  	  To	  assess	  and	  follow	  gene	  expression	  changes	  during	  Ascl1-­‐induced	  MEFs	  reprogramming	   globally,	   I	   took	   advantage	   of	   transcriptome-­‐wide	   expression	  microarrays.	   The	   experimental	   setup	   and	   quality	   control	   were	   described	  previously.	   mRNA	   samples	   were	   hybridized	   to	   llumina	   Ref8v2	   BeadArrays	  (performed	   by	   Harsha	   Jani,	   NIMR	   sequencing	   facility)	   and	   analysed	   using	   the	  GeneSpring	   software.	  The	  minimum	  requirements	   for	   significantly	  deregulated	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(SD)	  genes	  were	  a	  corrected	  p-­‐value	  lower	  than	  0.05	  and	  a	  relative	  fold	  change	  higher	  than	  2.	  As	  shown	  in	  Figure	  3.2	  A,	  the	  number	  of	  SD	  genes	  was	  determined	  for	   each	   experiment.	   In	   experiment	   A1,	   only	   3	   genes	   fulfil	   the	   minimum	  requirements,	  the	  data	  was	  not	  considered	  for	  further	  analysis.	  246	  genes	  were	  commonly	   deregulated	   in	   A2,	   B1	   and	   B2	   (205	   up	   regulated	   and	   41	   down	  regulated,	  Figure	  3.2	  C).	   In	  order	   to	  validate	   the	  quality	  of	   the	  gene	  expression	  profiling	  data,	  5	  SD	  genes	  were	  cherry	  picked	  from	  the	  pool	  of	  205	  up	  regulated	  genes	   and	   the	   expression	   level	   were	   validated	   using	   qPCR.	   Samples	   used	   for	  expression	  microarrays	  were	  used	  for	  qPCR	  validation	  (the	  expression	  of	  Atoh8	  and	  Sox8	  were	  tested	  for	  experiment	  B1	  and	  B2	  due	  to	  lack	  of	  mRNA	  materials).	  All	   genes	   validated	   showed	   significant	   up	   regulation	   under	   the	   Ascl1	   GoF	  condition,	  which	  suggested	  the	  gene	  expression	  profiles	  were	  reliable	  (Figure	  3.2	  D).	   To	  have	  global	  understanding	  of	  functions	  of	  Ascl1	  downstream	  genes	  at	  early	   stage	   of	   MEFs	   reprogramming,	   the	   246	   commonly	   SD	   genes	   were	  annotated	   to	   functional	   clusters	   using	   Gene	   Ontology	   (GO)	   analysis	  (http://david.abcc.ncifcrf.gov/).	  The	  top	  ten	  functional	  clusters	  for	  up	  regulated	  (Figure	  3.3	  A)	  and	  down	  regulated	  genes	  (Figure	  3.3	  B)	  were	  manually	  grouped	  based	   on	   boarder	   GO	   terms.	   No	   functional	   cluster	   related	   with	   neuronal	  development	   was	   observed	   from	   GO	   analysis	   (Figure	   3.3;	   data	   not	   shown).	  However,	  we	  indeed	  identified	  a	  number	  of	  up	  regulated	  genes	  that	  are	  know	  to	  be	   involved	   in	  neuronal	  development	  by	  manual	   screening,	  eg:	  Hes6	   (Bae	  et	  al	  2010),	  Zfp238	  (Batbet	  et	  al,	  2012	  and	  Okado	  et	  al,	  2009)	  and	  Atoh8	  (Inoue	  et	  al,	  2001).	  These	  suggest	  ectopic	  expression	  of	  Ascl1	  is	  able	  to	  induce	  the	  activation	  of	  neuronal	  specific	  genes	  at	  early	  stage	  of	  MEFs	  reprogramming.	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Figure	  3.2:	  Identification	  of	  Ascl1	  downstream	  genes	  using	  transcriptome-­
wide	  expression	  microarrays	  Experimental	  setups	  for	  transcriptome-­‐wide	  expression	  microarrays	  to	   identify	  Ascl1	   downstream	   genes	   at	   the	   early	   stage	   of	   MEFs	   reprogramming	   (A).	   The	  expression	   of	   Ascl1	   and	   Dll3	   is	   validated	   using	   single	   gene	   qPCR	   as	   quality	  control.	   RNA	   samples	   used	   are	   collected	   from	   three	   biological	   replicates	   (B).	  Numbers	   of	   SD	   genes	   (p-­‐value	   ≤	   0.05	   and	   fold	   change	   ≥2)	   in	   individual	  experiment	   (A).	   The	   number	   of	   commonly	   deregulated	   genes	   between	  experiment	  A2,	  B1	  and	  B2	  (C).	  The	  expression	  microarray	  data	  are	  validated	  by	  single	  gene	  qPCR.	  All	   genes	  validated	   show	  significant	  up	   regulation	  under	   the	  Ascl1	  GoF	  condition	  (D,	  see	  main	  text	  for	  details).	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Figure	  3.3:	  Gene	  ontology	  (GO)	  analysis	  of	  Ascl1	  downstream	  genes	  Enrichment	   of	   Gene	   Ontology	   biological	   process	   terms	   in	   Ascl1	   downstream	  genes	  at	  early	  stage	  of	  MEFs	  reprogramming.	  Number	  of	  genes	  in	  each	  category	  is	  shown.	  Functional	  clusters	  for	  up-­‐regulated	  (A)	  and	  down-­‐regulated	  genes	  (B)	  were	  manually	  grouped	  based	  on	  boarder	  GO	  terms.	  	  	  	  
	   45	  
3.4	  Selection	  of	  Ascl1	  downstream	  gene	  for	  further	  study	  At	   early	   stages	   of	   reprogramming,	   a	   large	   number	   of	   genes	   were	  deregulated	  upon	  forced	  expression	  of	  Ascl1.	  We	  decided	  to	  focus	  on	  205	  genes	  that	   were	   significantly	   up	   regulated,	   which	   were	   potentially	   involved	   in	   the	  activation	   of	   neuronal	   specific	   program(s)	   in	   MEFs.	   Known	   functions	   of	   these	  genes	  were	  manually	  checked	  (http://www.uniprot.org/).	  As	  mentioned	  earlier,	  we	  were	  focusing	  on	  identifying	  common	  target	  genes	  of	  Ascl1	  involved	  in	  both	  MEF	   reprogramming	   and	   NS	   cell	   differentiation.	   Taking	   the	   advantage	   that	  genome	  wide	   expression	   profile	   for	   Ascl1-­‐induced	   NS5	   cell	   differentiation	   has	  been	   generated	   previously	   (Ben	   Martynoga,	   unpublished	   data).	   By	   cross-­‐referencing	  the	  two	  data	  sets,	  we	  cherry	  picked	  3	  potential	  candidates	  (Zfp238,	  Sox8	  and	  Atoh8)	  from	  the	  70	  commonly	  up	  regulated	  genes	  in	  both	  programmes	  (Figure	  3.4).	   The	  up	   regulation	   of	   the	   candidate	   genes	  was	   confirmed	  using	  q-­‐PCR	  (Figure	  3.2	  D).	  	  Zfp238	   positively	   regulates	   MyoD-­‐mediated	   skeletal	   myogenesis	  (Yokoyama	   et	   al,	   2009)	   and	   is	   essential	   for	   granule	   neuron	  precursors	   (GNPs)	  differentiation	  and	  cell	  cycle	  regulation	  (Tatard	  et	  al,	  2010).	  Recent	  studies	  have	  also	   shown	   Zfp238	   is	   essential	   for	   cortical	   neuron	   development	   (Batbet	   et	   al,	  2012).	  Atoh8	  is	  a	  bHLH	  TF	  that	  promotes	  neurogenesis	  while	  inhibit	  gliogenesis	  in	   developing	   retina	   (Inoue	   et	   al,	   2001).	   Sox8	   is	   a	  member	   of	   the	   SoxE	   group.	  Sox9	   and	   Sox10	   are	   the	   other	   two	   members	   of	   the	   group	   and	   have	   been	  extensively	   studied	   in	   the	   past	   years	   to	   show	   their	   critical	   functions	   in	  specification	  and	  maintenance	  of	   stem	  cells	   (Scott	   et	   al,	   2010;	  Kim	  et	   al,	   2003;	  reviewed	  by	  Sarkar	  and	  Hochedlinger,	  2012).	  However,	  the	  function	  of	  Sox8	  has	  not	  been	  well	  established.	  	  Following	  the	  selection	  of	  candidates,	  we	  decided	  to	  use	  both	  GoF	  and	  LoF	  approaches	   to	   assess	   whether	   a	   candidate	   gene	   would	   affect	   Ascl1-­‐mediated	  reprogramming.	  For	  the	  rest	  of	  the	  chapter,	  I	  am	  going	  to	  focus	  on	  Sox8.	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Figure	  3.4:	  Identification	  of	  Ascl1	  downstream	  genes	  involved	  in	  both	  NSC	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3.5	  Sox8	  is	  involved	  in	  Ascl1-­induced	  MEFs	  reprogramming	  Sox8	   is	   up	   regulated	   at	   the	   early	   stage	   of	   Ascl1-­‐induced	   MEF	  reprogramming,	   the	   first	   questions	   we	   asked	   were:	   whether	   up	   regulation	   of	  Sox8	  was	  essential	   in	   the	   reprogramming	  process;	   could	  Sox8	   replace	  Ascl1	   to	  induce	  efficient	  MEF	  reprogramming	  or	  enhance	  Ascl1-­‐induced	  reprogramming	  efficiency.	   To	   address	   these	   questions,	   Sox8	   GoF	   and	   LoF	   studies	   were	  performed.	  	  	  
3.5.1	  Sox8	  GoF	  reduces	  the	  generation	  of	  induced	  neurons	  (iNs)	  To	   assess	   whether	   Sox8	   could	   replace	   Ascl1	   or	   enhance	   Ascl1	   activity	  during	  MEF	  reprogramming,	  Sox8	  was	  co-­‐expressed	  under	  BAM,	  BM	  and	  Ascl1	  only	  conditions.	  Antibody	  against	  neuronal	  class	  III	  β-­‐tubulin	  (Tuj1)	  was	  used	  to	  detect	  the	  generation	  of	  iN	  at	  day	  7	  and	  day	  13	  post-­‐infection.	  	  At	  day	  7,	  co-­‐expression	  of	  Sox8	  in	  the	  BAM	  cultures	  led	  to	  a	  40%	  increase	  in	  number	  of	  immature	  neurons.	  However,	  it	  had	  no	  effect	  on	  the	  generation	  of	  iN	  and	  the	  reprogramming	  efficiency	  (Figure	  3.5	  A,	  A’,	  D	  and	  D’).	  These	  suggest	  that	   ectopic	   expression	   of	   Sox8	   cannot	   enhance	   Ascl1-­‐mediated	   MEF	  reprogramming	  efficiency.	  Under	  the	  BM	  culture	  condition,	  ectopic	  expression	  of	  Sox8	   had	   little	   effect	   on	   the	   generation	   of	   immature	   neurons	   and	   iN,	   which	  indicates	   that	   Sox8	   cannot	   replace	   Ascl1	   during	   the	   reprogramming	   process	  (Figure	  3.5	  B,	  B’,	  D	  and	  D’).	  Under	  the	  Ascl1	  only	  condition,	  ectopic	  expression	  of	  Sox8	  had	  no	  clear	  effect	  on	  the	  generation	  of	  immature	  neurons	  but	  reduced	  the	  number	   of	   iNs.	   The	   reprogramming	   efficiency	   was	   reduced	   from	   10%	   to	   4%	  (Figure	  3.5	  C,	  C’,	  D	  and	  D’).	  These	  suggest	  the	  possibility	  that	  Sox8	  is	  involved	  in	  generating	  mature	  neurons	  from	  MEFs.	  Furthermore,	  no	  Tuj1-­‐positive	  cells	  were	  observed	   under	   the	   Sox8	   only	   condition	   (Figure	   3.5	   D,	   data	   not	   shown).	   This	  suggests	  Sox8	  is	  unable	  to	  activate	  neuronal	  specific	  programs	  in	  MEFs.	  Similar	  results	  were	  observed	  at	  day	  13	  cultures	  (Figure	  3.5	  E	  and	  E’,	  data	  not	  shown).	  	  In	   conclusion,	   our	   GoF	   studies	   have	   shown	   that	   Sox8	   cannot	   enhance	  reprogramming	   efficiency	   under	   the	   3-­‐TF	   condition	   and	   is	   unable	   to	   replace	  Ascl1	   during	   the	   reprogramming	   process.	   Furthermore,	   Sox8	   is	   potentially	  involved	   in	  generation	  of	  mature	  neurons.	  These	  will	  be	  discussed	   further	   in	  a	  later	  section.	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Figure	  3.5:	  Sox8	  reduces	  the	  generation	  of	  MEFs	  iNs	  P3	  MEFs	  were	  co-­‐infected	  with	  Sox8	  viruses	  in	  combination	  with	  BAM,	  BM	  and	  Ascl1	  alone	  (A-­‐C).	  Sox8	  expression	  has	  no	  effect	  on	  the	  generation	  of	  MEFs	   iNs	  under	  BAM	   (A)	   and	  BM	   (B)	   conditions	  7	  days	   after	   infection.	   Co-­‐expression	  of	  Sox8	  with	  Ascl1	  alone	   reduces	   the	  generation	  of	   iNs	  7	  days	  after	   infection	   (C).	  The	   quantification	   graphs	   show	   the	   number	   of	   Tuj1-­‐positive	   cells/unit	   area	  under	   20x	   objective	   and	   the	   reprogramming	   efficiency	   (calculated	   using	   only	  iNs)	  when	   Sox8	   is	   co-­‐expressed	   under	   BAM,	   BM	   and	   Ascl1	   alone	   conditions	   7	  days	   (D	  and	  D’)	  and	  13	  days	   (E	  and	  E’)	  after	   infection.	  Sox8	  alone	   is	  unable	   to	  generate	   Tuj1-­‐positive	   cells	   7	   days	   (D	   and	   D’)	   and	   13	   days	   (E	   and	   E’)	   after	  infection.	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3.5.2	   Sox8	  LoF	   reduces	  Ascl1-­mediated	  generation	  of	  neuronal	   cells	   from	  
MEFs	   shRNA-­‐mediated	  knock	  down	  approach	  was	  used	  to	  study	  whether	  Sox8	  activity	  was	  essential	  for	  Ascl1-­‐mediated	  MEFs	  reprogramming.	  shRNAs	  against	  Sox8	   were	   designed	   using	   Whitehead	   siRNA	   (http://sirna.wi.mit.edu/)	   and	  cloned	   into	   viral	   vector	   contains	   a	   GFP	   reporter.	   MEFs	   were	   co-­‐infected	   with	  lentiviruses	   carrying	   Ascl1	   transgene	   (Sox8	   is	   not	   endogenously	   expressed	   in	  MEFs	  and	  Ascl1	  was	  used	  to	  induce	  Sox8	  expression)	  and	  Sox8	  shRNA.	  Dox	  was	  added	   24h	   post-­‐infection	   to	   induce	   Ascl1	   expression	   and	   the	   knock	   down	  efficiency	  was	  assessed	  using	  q-­‐PCR	  72h	  post-­‐infection	  (Figure	  3.6	  A).	  The	  most	  efficient	   construct	   was	   used	   for	   Sox8	   LoF	   studies,	   which	   showed	   a	   60%	  reduction	  of	  Sox8	  expression	  at	  the	  RNA	  level	  (Figure	  3.6	  B).	  	  To	   assess	   whether	   Sox8	   activity	   was	   essential	   for	   Ascl1-­‐induced	   MEF	  reprogramming.	  MEFs	  were	   co-­‐infected	  with	   lentiviruses	   carrying	   Sox8	   shRNA	  and	  BAM	  TFs	  or	  Ascl1	  alone	  and	  analysed	  at	  day	  7	  and	  day	  13	  post-­‐infection.	  At	  day	  7,	  no	  clear	  changes	   in	  cell	  morphology	  and	  reprogramming	  efficiency	  were	  observed	  under	  the	  BAM	  condition	  (Figure	  3.7	  A,	  A’,	  E	  and	  E’).	  Under	  the	  Ascl1	  only	  condition,	  co-­‐infection	  with	  Sox8	  shRNA	  reduced	  the	  number	  of	   immature	  neurons	  by	  50%,	  but	  had	  no	  effects	  on	  reprogramming	  efficiency	  (Figure	  3.7	  B,	  B’,	  E	  and	  E’).	  At	  day	  13,	  Sox8	  LoF	  reduced	  reprogramming	  efficiency	  under	  both	  BAM	   and	   Ascl1	   only	   conditions,	   but	   had	   no	   clear	   effect	   on	   the	   generation	   of	  immature	  neurons	  in	  both	  conditions	  (Figure	  3.7	  C,	  C’,	  D,	  D’,	  F	  and	  F’).	  	  	  In	   conclusion,	  LoF	   studies	  have	   shown	   that	   Sox8	  activity	   is	   required	   for	  Ascl1-­‐induced	  MEFs	   reprogramming.	  These	  will	   be	  discussed	   further	   in	   a	   later	  section.	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Figure	  3.6:	  shRNA-­mediated	  Sox8	  knock	  down	  Experimental	  design	  to	  test	  Sox8	  shRNA	  knock	  down	  efficiency	  (A).	  P3	  MEFs	  are	  co-­‐infected	  with	  lentivirus	  carrying	  Sox8	  shRNA	  and	  Ascl1.	  shRNA	  against	  Sox8	  reduces	  Ascl1-­‐induced	  Sox8	  up	  regulation	  by	  60%	  three	  days	  post-­‐infection	  (B).	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Figure	  3.7:	  Sox8	  is	  required	  for	  the	  generation	  of	  neuronal	  cell	  from	  MEFs	  Sox8	  shRNA	   is	   cloned	   into	  viral	  vector	   contains	  a	  GFP	  reporter.	  P3	  MEFs	  were	  co-­‐infected	  with	  Sox8	  shRNA	  viruses	  in	  combination	  with	  BAM	  and	  Ascl1	  alone	  (A-­‐D).	  Sox8	  LoF	  has	  no	  effect	  on	  the	  generation	  of	  MEFs	  iNs	  under	  BAM	  (A	  and	  A’)	   and	   reduced	   the	   generation	   of	   immature	   neurons	   under	   Ascl1	   alone	  condition	  (B	  and	  B”)	  7	  days	  after	   infection.	  Sox8	  LoF	  reduces	  the	  generation	  of	  iNs	   under	   both	   BAM	   and	   Ascl1	   alone	   conditions	   13	   days	   after	   infection	   (C-­‐D).	  The	   quantification	   graphs	   show	   the	   number	   of	   GFP-­‐,	   Tuj1-­‐doubel	   positive	  cells/unit	   area	   under	   20x	   objective	   and	   the	   reprogramming	   efficiency	  (calculated	  using	  only	  iNs)	  under	  BAM	  and	  Ascl1	  alone	  conditions	  7	  days	  (E	  and	  E’)	  and	  13	  days	  (F	  and	  F’)	  after	  infection.	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3.6	  Discussion	  	  In	   this	   chapter,	   I	   have	   shown	   that	  we	   successfully	   re-­‐established	   the	   in	  
vitro	   reprogramming	  protocol	  using	  MEFs	  as	   starting	   cells.	  The	  MEFs	   iNs	  have	  classical	  neuronal	  morphology	  (cells	  have	  bi-­‐polar	  or	  multi-­‐polar	  structure	  with	  long	  extended	  processes)	  and	  show	  strong	  immunoreactivity	  for	  early	  neuronal	  marker	   Tuj1.	   The	   combination	   of	   the	   three	   neurogenic	   TFs	   (Ascl1,	   Brn2	   and	  Myt1l)	   has	   the	   reprogramming	   efficiency	   between	   12%-­‐19%,	   which	   is	  comparable	   with	   pervious	   experiments	   (Vierbuchen	   et	   al,	   2010).	   Here,	   I	   will	  discuss	   our	   major	   finding,	   Sox8,	   a	   member	   of	   the	   SoxE	   family,	   is	   involved	   in	  Ascl1-­‐induced	  MEFs	  reprogramming.	  	  	  
3.6.1	  Sox8	  GoF	  reduces	  the	  generation	  of	  MEFs	  iNs.	  	  Sox8	   is	   up	   regulated	   at	   the	   early	   stage	   of	   Ascl1-­‐induced	   MEFs	  reprogramming.	  However,	  ectopic	  expression	  of	  Sox8	  reduces	  the	  generation	  of	  MEFs	  iN	  under	  Ascl1	  alone	  condition	  7	  and	  13	  days	  after	  infection	  (Figure	  3.5	  C-­‐E’,	   data	   not	   shown),	   which	   suggest	   the	   correct	   level	   or/and	   timing	   of	   Sox8	  expression	  is	  required	  to	  generate	  iNs.	  Furthermore,	  mass	  spectrometry	  analysis	  has	  shown	  that	  Sox8	  directly	  interact	  with	  Ascl1	  at	  the	  protein	  level	  (Debbie	  van	  den	  Berg,	   unpublished	  data).	   Luciferase	   reporter	   assays	   indicate	   that	   Sox8	   can	  act	   either	   cooperatively	   with	   or	   inhibitory	   to	   Ascl1	   activity	   in	   enhancer	  dependent	   manner	   (Cristina	   Minieri,	   unpublished	   data).	   These	   suggest	   the	  possibility	   that	   Sox8	   regulates	   Ascl1-­‐induced	   activation	   of	   neuronal	   specific	  genes.	  	  On	   the	   other	   hand,	   we	   are	   using	   neuronal	   morphologies	   to	   define	   iNs	  (cells	   have	   processes	   longer	   than	   three	   cell	   body	   length).	   The	   generation	   of	  immature	  neurons	  (cells	  have	  processes	  shorter	   than	  three	  cell	  body	   length)	   is	  not	   effected	   by	   Sox8	   overexpression	   (Figure	   3.5	   D	   and	   E).	   These	   suggest	   the	  possibility	  Sox8	  is	  involved	  in	  cytoskeletal	  arrangement	  during	  the	  generation	  of	  iNs.	  At	  the	  early	  stage	  of	  MEFs	  reprogramming,	  a	  number	  of	  Ascl1	  downstream	  genes	   that	   are	   up	   regulated	   have	   cytoskeletal	   remodelling	   activities.	   For	  example,	   Dpysl4	   is	   up	   regulated	   upon	   forced	   Ascl1	   expression	   in	   MEFs	   (up	  regulation	   is	   confirmed	   by	   q-­‐PCR,	   data	   not	   shown	   here)	   and	   it	   is	   involved	   in	  Sema3	   signalling	   and	   subsequently	   cytoskeletal	   remodelling	   (Goshima	   et	   al	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1995).	  These	  suggest	   the	  possibility	  Sox8	  regulates	  Aslc1-­‐induced	  activation	  of	  cytoskeletal	  remodelling	  genes.	  	  Furthermore,	   Sox8	   GoF	   is	   unable	   to	   generate	   Tuj1-­‐positive	   cells	   nor	  enhance	   Ascl1-­‐mediated	   reprogramming	   efficiency	   (Figure	   3.5	   D-­‐E’),	   which	  suggests,	  unlike	  Ascl1,	  Sox8	  or/and	  its	  downstream	  genes	  do	  not	  have	  chromatin	  remodelling	   activities	   to	   open	   chromatin	   structures	   during	   direct	  reprogramming	  of	  MEFs	  (also	  see	  3.3.2	  for	  further	  discussion).	  	  	  
3.6.2	  Sox8	  LoF	  reduces	  the	  generation	  of	  neuronal	  cells	  from	  MEFs	  Sox8	   LoF	   reduces	   the	   generation	   of	   immature	   neurons	   at	   day	   7	   post-­‐infection	   under	   the	   Ascl1	   alone	   condition,	   but	   has	   no	   noticeable	   effect	   on	   the	  mature	  neuron	  population	  in	  both	  efficiency	  and	  cell	  morphologies	  (Figure	  3.7	  E	  and	  E’).	  At	  day	  13,	   the	  reduction	   in	   iNs	  can	  be	  partly	  explained	  by	  the	  reduced	  immature	   neuronal	   population	   at	   day	   7	   (Figure	   3.7	   F	   and	   F’).	   However,	   the	  overall	   reduction	   in	   the	   generation	   of	   Tuj1-­‐positive	   cells	   at	   both	   time	   points	  suggests	   that	   Sox8	   is	   required	   for	   Ascl1-­‐mediated	   activation	   of	   the	   neuronal	  program	  in	  MEFs.	  Recent	  studies	  have	  shown	  that	  Ascl1	  functions	  as	  a	  “pioneer	  factor”	   in	   the	   direct	   reprogramming	   process.	   ChIP-­‐Seq	   experiment	   has	   shown	  that	   Ascl1	   binding	   potentially	   opens	   the	   chromatin	   structure	   and	   allows	   other	  TFs	   (such	   as	   Brn2)	   to	   bind	   at	   the	   correct	   positions	   at	   the	   early	   stage	   of	  reprogramming	   (Wapkinski	   et	   al,	   2013).	   These	   suggest	   that	   Sox8	   is	   required,	  alone	   or	   together	   with	   Ascl1,	   to	   regulate	   a	   set	   of	   genes	   involved	   in	  reprogramming	  mechanisms.	  Whether	   Sox8	   is	   involved	   in	   the	   Ascl1-­‐mediated	  genome-­‐wide	  chromatin	  structural	  change	  is	  unknown.	  However,	  Sox8	  does	  not	  seem	   to	   have	   chromatin	   remodelling	   activities,	   as	   ectopic	   expression	   of	   Sox8	  alone	  is	  unable	  to	  generate	  Tuj1-­‐positive	  cells.	  (also	  see	  3.3.1).	  Furthermore,	   the	   additional	   expression	   of	   Brn2	   and	   Myt1l	   seems	   to	  compensate	  Sox8	  LoF	  at	   the	  early	   stage	   (Figure	  3.7	  E	  and	  E’).	  This	  may	  due	   to	  that	   Brn2	   or/and	   Myt1l	   share	   common	   target	   genes	   with	   Sox8,	   which	  compensates	  Sox8	  activity	  at	  the	  early	  stage.	  	  However,	  the	  mechanism	  remains	  unclear.	  	  	  	  
	   56	  
3.7	  Conclusion	  and	  proposed	  model	  Our	   GoF	   and	   LoF	   studies	   have	   shown	   that	   Sox8	   is	   involved	   in	   Ascl1-­‐induced	  neuronal	  program	  activation	  during	  MEFs	  reprogramming.	  Preliminary	  studies	   suggest	   the	   possibility	   that	   this	   is	   due	   to	   Sox8	   affects	   Ascl1	   activity	   in	  regulating	   genes	   involved	   in	   neuronal	   development.	   Furthermore,	   as	   Sox8	   is	  indeed	  up	  regulated	  at	  early	  stage	  of	  the	  reprogramming	  process	  (Figure	  3.2	  D)	  and	   both	   GoF	   and	   LoF	   of	   Sox8	   reduce	   the	   generation	   of	   neuronal	   cells	   from	  MEFs,	   it	   is	   possible	   that	   the	   expression	  of	   Sox8	   is	   transient	   and	   it	   needs	   to	   be	  dissolved	   to	   allow	   the	   reprogramming	   process	   to	   complete	   (Figure	   3.8).	   This	  model	   may	   partly	   explain	   that	   Sox8	   GoF	   and	   LoF	   have	   similar	   phenotypes.	  However,	   at	   which	   stage	   of	   the	   reprogramming	   process	   Sox8	   needs	   to	   be	  dissolved	  is	  unclear.	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Chapter	  4:	  Functions	  of	  SoxE	  in	  neural	  stem	  cell	  
maintenance	  in	  vitro	  
	  
4.1	  Rational,	  hypothesis	  and	  aim	  Pervious	   studies	   have	   shown	   that	   Ascl1	   regulates	   genes	   involved	   in	   all	  steps	   of	   neurogenesis	   in	   a	   direct	   manner	   (Castro	   et	   al,	   2011).	   In	   situ	  hybridization	  data	  have	  shown	  that	  Sox8	  is	  highly	  expression	  in	  ventricular	  zone	  (VZ)	   and	   subventricular	   zone	   (SVZ)	   in	   the	   developing	   mouse	   telencephalon,	  which	   contain	   the	   proliferating	   progenitor	   population	   (Figure	   4.1	   A).	   The	  expression	  pattern	  is	  partly	  overlapped	  with	  Ascl1	  (Figure	  4.1	  C).	  I	  have	  shown	  that	   Sox8	   is	   involved	   in	   the	   activation	   of	   Ascl1-­‐induced	   neuronal	   specific	  program	   during	   MEFs	   reprogramming.	   Genome	   wide	   expression	   profile	  indicates	  that	  Sox8	  is	  up	  regulated	  during	  Ascl1-­‐induced	  NS5	  cell	  differentiation	  (Ben	  Martynoga,	  unpublished	  data).	  Furthermore,	  preliminary	  data	  have	  shown	  that	  Sox8	  directly	  interact	  with	  Ascl1	  at	  the	  protein	  level	  (Debbie	  van	  den	  Berg,	  unpublished	  data)	  and	  acts	  either	  cooperatively	  with	  or	  inhibitory	  to	  Ascl1	  in	  an	  enhancer	  dependent	  manner	  (Cristina	  Minieri,	  unpublished	  data).	  	  These	  suggest	  Sox8	  is	  involved	  in	  Ascl1-­‐induced	  neuronal	  differentiation.	  	  Furthermore,	   In	   situ	   hybridization	   data	   have	   also	   shown	   that	   Sox9,	  another	  member	  of	   the	  SoxE	  group,	  has	   the	  similar	  expression	  pattern	  as	  Sox8	  (Figure	   4.1	   B).	   In	   addition,	   GoF	   and	   LoF	   studies	   using	   transgenic	  mouse	   lines	  have	   show	   that	   Sox9	   is	   involved	   in	   the	   generation	   and	  maintenance	   of	   neural	  stem	  cell	   in	  developing	  CNS	   (Scott	   et	   al,	   2010).	  Also,	   the	  DNA	  binding	  domain,	  high	  mobility	  group	  (HMG),	  is	  highly	  conserved	  between	  Sox8	  and	  Sox9	  (Figure	  4.1	  D),	  which	  suggests	  the	  function	  redundancy	  between	  the	  two	  members	  of	  the	  SoxE	   group.	   These	   data	   raise	   the	   possibility	   that	   Sox8	   is	   involved	   in	   NSC	  maintenance.	  Based	   on	   the	   data	   mentioned	   above,	   we	   hypothesised	   that	   Sox8	   is	  involved	  in	  NSC	  maintenance	  and	  differentiation.	  	  Indeed,	  Sox9	  has	  been	  shown	  to	  be	  involved	  in	  NSC	  maintenance	  (Scott	  et	  al,	   2010).	   However,	   the	   molecular	   mechanism	   remains	   unclear.	   Also,	   due	   to	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possible	  functional	  redundancy	  between	  the	  two	  members,	  I	  decided	  to	  include	  Sox9	  in	  my	  studies.	  	  To	  assess	  whether	  SoxE	  (specifically	  Sox8	  and	  Sox9)	  was	  involved	  in	  NSC	  maintenance	  and	  differentiation,	  I	  decided	  to	  use	  both	  GoF	  and	  LoF	  approaches	  and	   NS5	   as	   the	   in	   vitro	   system.	   As	   shown	   in	   earlier	   experiments,	   Sox8	   GoF	   is	  involved	  in	  Ascl1-­‐induced	  generation	  of	  iNs	  from	  MEFs.	  Using	  similar	  approach,	  Ascl1	  and	  SoxE	  were	  co-­‐expressed	  to	  assess	  SoxE	  functions	  in	  regulating	  Ascl1-­‐mediated	  NSC	  differentiation.	  shRNA-­‐mediated	  KD	  approach	  was	  used	  to	  assess	  whether	   SoxE	   was	   involved	   in	   maintaining	   NSCs	   in	   a	   undifferentiated	  proliferating	  state.	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Figure	   4.1:	   Expression	   of	   Sox8,	   Sox9	   and	   Ascl1	   in	   E14.5	   mouse	  
telencephalon	  and	  graphical	  view	  of	  Sox8	  and	  Sox9	  protein	  
In	   situ	  hybridization	  data	   to	  show	  the	  expression	  pattern	  of	  Sox8	  (A),	  Sox9	  (B)	  and	  Ascl1	  (C)	  in	  E14.5	  mouse	  telencephalon.	  A	  graphical	  view	  of	  Sox9	  and	  Sox8	  proteins	   (D).	   The	   DNA	   binding	   domain	   (High	   Mobility	   Group:	   HMG)	   is	   highly	  conserved	  and	  the	  position	  is	  highlighted.	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4.2	  SoxE	  inhibits	  Ascl1-­induced	  NSC	  differentiation	  in	  vitro	  Sox8	   or	   Sox9	  was	   co-­‐transfected	  with	   Ascl1	   to	   assess	   its	   function(s)	   in	  Ascl1-­‐induced	  NSC	  differentiation.	  To	  ensure	  all	  cells	  transfected	  with	  Ascl1	  also	  received	  Sox8	  or	  Sox9,	  the	  ratio	  of	  the	  amount	  of	  DNA	  between	  Ascl1	  and	  Sox8	  or	  Sox9	   was	   1:3.	   Antibody	   against	   neuronal	   maker	   Tuj1	   was	   used	   to	   identify	  differentiated	   neuronal	   cells	   24h	   and	   48h	   post-­‐transfection	   (Figure	   4.2	   A).	   No	  Tuj1-­‐positive	   cells	   were	   observed	   when	   un-­‐transfected	   at	   both	   time	   points	  (Figure	   4.2	   B	   and	   B’).	   Ectopic	   expression	   of	   Ascl1	   triggered	   neuronal	  differentiation	  of	  NSCs,	  which	  was	   indicated	  by	   the	  Tuj1	   staining	   (Figure	  4.2	  C	  and	  C’).	  The	  number	  of	  Tuj1-­‐positive	  cells	  was	  clearly	  reduced	  when	  cells	  were	  co-­‐transfected	  with	  Sox8	  (Figure	  4.2	  D	  and	  D’)	  or	  Sox9	  (Figure	  4.2	  E	  and	  E’)	  at	  both	   time	   points.	   The	   observation	   was	   confirmed	   by	   quantification.	  Overexpression	   of	   Sox8	   or	   Sox9	   significantly	   reduced	   the	   generation	   of	   Tuj1-­‐positive	  cells,	  which	  was	  induced	  by	  ectopic	  expression	  of	  Ascl1.	  The	  percentage	  of	  Tuj1-­‐positive	  cells	  was	  reduced	  from	  5%	  and	  3%	  to	  less	  than	  1%	  at	  24h	  and	  48h	  time	  points	  (Figure	  4.2	  F).	  	  These	   data	   suggest	   that	   SoxE	   inhibits	   Ascl1-­‐induced	   neuronal	  differentiation	  of	  NSCs	  in	  vitro.	  This	  will	  be	  discussed	  further	  in	  later	  section.	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4.3	  SoxE	  activity	  is	  involved	  in	  NSC	  proliferation	  in	  vitro	  To	   assess	   whether	   SoxE	   is	   involved	   in	   NSC	   proliferation,	   I	   decided	   to	  perform	  SoxE	  LoF	  studies	  using	  shRNA-­‐mediated	  KD	  approach.	  shRNAs	  against	  Sox8	  or	  Sox9	  were	  designed	  using	  Whitehead	   siRNA	   (http://sirna.wi.mit.edu/)	  and	  cloned	   into	  a	  plasmid	  contains	  puromycin	  resistance	  cassette	   for	  selection.	  q-­‐PCR	  and	  western	  blot	  were	  used	  to	  examine	  the	  KD	  efficiency	  at	  both	  mRNA	  and	  protein	  level.	  Due	  to	  possible	  functional	  redundancy	  between	  Sox8	  and	  Sox9,	  the	   Sox8-­‐Sox9	   double	   KD	   experiment	   was	   also	   performed	   to	   avoid	   functional	  compensation	  between	  the	  SoxE	  members.	  	  	  
4.3.1	   shRNA-­mediated	   KD	   efficiently	   reduces	   the	   expression	   of	   Sox8	   and	  
Sox9	   Due	   to	   lack	   of	   antibody	   against	   Sox8	   protein,	   an	   inducible	   cells	   line	  overexpressing	   V5-­‐taged	   Sox8	   was	   generated	   from	   NS5	   cells	   (iSox8-­‐V5	   NSC).	  Pruomycine	  was	  added	  16h	  post-­‐transfection	  for	  selection	  and	  doxycycline	  was	  used	   to	   induce	   the	   expression	   of	   V5	   tagged	   Sox8	   protein.	   RNA	   and	   protein	  samples	   were	   collected	   72h	   post-­‐transfection	   (Figure	   4.3	   A).	   The	   presence	   of	  doxycycline	   induced	   the	   expression	   of	   V5-­‐tagged	   Sox8	   (Figure	   4.3	   A’’	   and	   A’’).	  The	  q-­‐PCR	  analysis	  showed	  a	  60%	  and	  70%	  reduction	  of	  Sox8	  expression	  at	  the	  RNA	  level	  in	  the	  single	  and	  double	  KD	  experiments	  (Figure	  4.3	  A’).	  The	  western	  blot	   experiment	   indicated	   a	   clear	   reduction	   of	   V5-­‐tagged	   Sox8	   protein,	   which	  was	  absence	  without	  doxycycline	  induction	  (Figure	  4.3	  A’’).	  NS5	  cells	  were	  used	  to	  assess	  the	  KD	  efficiency	  of	  the	  Sox9	  shRNA	  (Figure	  4.3	  B).	  Similarly,	  protein	  and	  RNA	  samples	  were	  collected	  72h	  post	  transfection	  with	   56h	   puromycine	   selection.	   q-­‐PCR	   analysis	   showed	   a	   50%	   and	   40%	  reduction	  of	  Sox9	  RNA	  under	  single	  and	  double	  KD	  conditions	  (Figure	  4.3	  B’).	  At	  the	  protein	  level,	  the	  expression	  of	  Sox9	  was	  clearly	  reduced	  (Figure	  4.3	  B’’).	  	  In	   summary,	   shRNA	   against	   Sox8	   or	   Sox9	   efficiently	   reduces	   the	  expression	   of	   its	   target	   gene	   at	   both	   transcriptional	   and	   translational	   levels	  under	  both	  single	  and	  double	  KD	  conditions.	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Figure	  4.3:	  shRNA–mediated	  SoxE	  knock	  down	  Experimental	   design	   to	   test	   shRNA	   knock	   down	   efficiency	   (A	   and	   B).	   q-­‐PCR	  analysis	   to	   examine	   the	   reduction	  of	   Sox8	   (A’)	   and	  Sox9	   (B’)	   expression	  at	   the	  RNA	   level	   under	   single	   and	   double	   KD	   conditions.	  Western	   blot	   to	   assess	   the	  reduction	   of	   V5-­‐tagged	   Sox8	   (A’’)	   and	   Sox9	   (B’’)	   protein.	   q-­‐PCR	   analysis	   to	  indicate	  the	  up-­‐regulated	  of	  Sox8	  expression	  	  after	  doxycycline	  induction	  (A’’’).	  	  	  	  
	   65	  
4.3.2	   SoxE	   is	   essential	   for	  NSC	  proliferation	  but	  not	   required	   to	  maintain	  
NSC	  in	  an	  undifferentiated	  state	  shRNA-­‐mediated	   SoxE	   KD	   approach	   was	   used	   to	   assess	   whether	   SoxE	  activity	  was	   involved	   in	  NSC	  proliferation.	  shRNA	  against	  Sox8	  or	  Sox9	  was	  re-­‐cloned	  into	  a	  vector	  contains	  a	  GFP	  reporter.	  EdU,	  which	  was	  used	  to	  measure	  S-­‐phase	  progression,	  was	  applied	  48h	  post-­‐transfection	  for	  two	  hours	  (Figure	  4.4	  A).	  Under	  the	  control	  condition,	  more	  than	  40%	  of	  the	  transfected	  cells	  were	  able	  to	  enter	  S-­‐phase	  (Figure	  4.4	  B	  and	  C,	  indicated	  by	  EdU-­‐GFP	  double	  positive	  cells).	  The	   percentage	   of	   transfect	   cells	   entered	   S-­‐phase	  was	   significantly	   reduced	   to	  8%	   and	   19%	   under	   Sox8	   and	   Sox9	   LoF	   conditions	   (Figure	   4.4	   B’,	   B’’	   and	   C).	  Under	   the	  double	  KD	  condition,	   it	  was	  reduced	   to	   less	   than	  5%	  (Figure	  4.4	  B’’’	  and	  C).	  	  In	   addition,	   antibodies	   against	   Tuj1	   and	  DCX	   (neuronal	  markers),	   GFAP	  (an	   astrocyte	   marker),	   O4	   and	   NG2	   (oligodendrocyte	   markers)	   were	   used	   to	  assess	  whether	   SoxE	  was	   involved	   in	  maintaining	   NSCs	   in	   an	   undifferentiated	  state.	   However,	   GFP-­‐positive	   cells	   were	   not	   immunoactive	   to	   any	   of	   the	  antibodies,	  which	  was	  suggesting	  the	  transfected	  NSCs	  remains	  undifferentiated	  (data	  not	  shown).	  The	  preliminary	  data	  have	  show	  that	  SoxE	  activity	  is	  essential	  to	  maintain	  NSC	   proliferation	   in	   vitro.	   Furthermore,	   there	   is	   no	   functional	   compensation	  between	  Sox8	  and	  Sox9	  in	  regulating	  NSC	  proliferation.	  These	  will	  be	  discussed	  in	  a	  later	  section.	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Figure	  4.4:	  SoxE	  activities	  are	  essential	  in	  maintaining	  NSC	  proliferation	  Experimental	  design	  to	  assess	  SoxE	  functions	  in	  NSC	  proliferation	  (A).	  Sox8	  LoF	  (B’),	  Sox9	  LoF	  (B’’)	  and	  Sox8-­‐Sox9	  double	  KD	  (B’’’)	  reduced	  the	  number	  of	  EdU	  positive	   cells	   (red)	   within	   the	   transfected	   population	   (green)	   comparing	   with	  control	  (B).	  The	  quantification	  graph	  shows	  percentage	  EdU-­‐GFP	  double	  positive	  cells	   50h	   post-­‐transfection	   (C).	   Data	   shown	   are	   mean	   of	   two	   independent	  biological	  replicates.	  Error	  bar:	  mean	  ±	  SEM.	  t	  test:	  **p<0.01.	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4.3.3	  Identification	  of	  SoxE	  downstream	  genes	  Our	   preliminary	   data	   have	   shown	   that	   SoxE	   activity	   is	   essential	   to	  maintain	   NSC	   proliferation.	   In	   order	   to	   understand	   the	   molecular	   mechanism	  involved,	   I	  decided	   to	  use	  genome-­‐wide	  expression	  microarrays	   to	  detect	   gene	  expression	  changes	  under	  SoxE	  LoF	  conditions.	  RNA	  samples	  were	  collected	  72h	  post	   transfection	   with	   56h	   puromycine	   selection	   (Figure	   4.5	   A)	   and	   collected	  from	  three	  biological	  replicates.	  As	  a	  quality	  control,	  q-­‐PCR	  analysis	  was	  used	  to	  assess	  SoxE	  knock	  down	  efficiency	  and	  showed	  a	  40%-­‐70%	  reduction	  at	  the	  RNA	  level	  under	  single	  and	  double	  KD	  conditions	  (Figure	  4.5	  B).	  mRNA	  samples	  were	  hybridized	   to	   llumina	   Ref8v2	   BeadArrays	   (performed	   by	   Harsha	   Jani,	   NIMR	  sequencing	  facility)	  and	  analysed	  using	  the	  GeneSpring	  software.	  The	  minimum	  requirements	  for	  significantly	  deregulated	  (SD)	  genes	  were	  a	  corrected	  p-­‐value	  lower	  than	  0.05	  and	  a	  relative	  fold	  change	  higher	  than	  1.5.	  In	  order	   to	  validate	   the	  quality	  of	   the	  gene	  expression	  profiling	  data,	  12	  SD	   genes	   were	   cherry	   picked	   (6	   up-­‐regulated	   and	   6	   down-­‐regulated)	   and	   the	  expression	   level	   were	   validated	   using	   q-­‐PCR.	   Samples	   used	   for	   expression	  microarrays	   and	   two	   additional	   biological	   replicates	   were	   used	   for	   q-­‐PCR	  validation.	  The	  11	  out	  of	  12	  genes	  validated	  were	  significant	  deregulated	  under	  the	   SoxE	   LoF	   conditions,	   which	   suggested	   the	   gene	   expression	   profiles	   were	  reliable	  (data	  not	  shown).	  	  The	  numbers	  of	  SD	  genes	  for	  single	  and	  double	  KD	  were	  shown	  in	  Figure	  4.5	   C.	   Comparing	   Sox8	   and	   Sox9	   single	   KD	   conditions,	   520	   genes	   were	  deregulated	   by	   Sox8	   shRNA	  only	   (255	   down	   regulated	   and	   265	   up	   regulated).	  875	  genes	  were	  de-­‐regulated	  by	  Sox9	  shRNA	  only	  (368	  down	  regulated	  and	  507	  up	   regulated).	   	   409	   genes	   were	   commonly	   de-­‐regulated	   by	   Sox8	   and	   Sox9	  shRNAs	   (157	   down	   regulated	   and	   252	   up	   regulated).	   724	   genes	   were	   de-­‐regulated	  under	  the	  double	  KD	  condition	  only	  (397	  down	  regulated	  and	  327	  up	  regulated)	   (Figure	   4.5	   C,	   D	   and	   D’).	   This	   will	   be	   discussed	   further	   in	   a	   later	  section.	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Figure	   4.5:	   Identification	   of	   SoxE	   down	   stream	   genes	   using	   genome-­wide	  
expression	  microarrays	  Experimental	   setups	   for	   transcriptome-­‐wide	   expression	   microarrays	   (A).	   The	  expression	  of	  Sox8	  or/and	  Sox9	  under	  single	  and	  double	  knock	  down	  conditions	  is	   validated	   using	   single	   gene	   qPCR	   as	   quality	   control.	   RNA	   samples	   used	   are	  collected	   from	   three	   biological	   replicates	   (B).	  Numbers	   of	   SD	   genes	   (p-­‐value	   ≤	  0.05	  and	  fold	  change	  ≥1.5)	  under	  single	  and	  double	  KD	  conditions	  (C).	  Number	  of	  commonly	   and	   uniquely	   SD	   genes	   under	   single	   and	   double	   knock	   down	  conditions	  (D	  and	  D’).	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4.3.4	  Functional	  annotation	  of	  SoxE	  downstream	  genes	  	  To	  have	  global	  understanding	  of	  functions	  of	  SoxE	  downstream	  genes,	  SD	  genes	  were	  annotated	   to	   functional	  clusters	  using	  Gene	  Ontology	  (GO)	  analysis	  (http://david.abcc.ncifcrf.gov/).	  The	  top	  ten	  functional	  clusters	  for	  up	  regulated	  (Sox8	   KD,	   Sox9	   KD,	   Sox8-­‐Sox9	   double	   KD,	   Figure	   4.6	   A’,	   B’	   and	   C’)	   and	   down	  regulated	  genes	  (Figure	  A,	  B	  and	  C)	  were	  manually	  grouped	  based	  on	  boarder	  GO	  terms.	  Under	   the	   Sox8	   knock	   down	   condition,	   genes	   involved	   in	   cell	   adhesion,	  sterol	   process	   and	   neuron	   development	   were	   down	   regulated.	   For	   clusters	  related	   with	   neuron	   development,	   no	   neuronal	   specific	   genes	   were	   down	  regulated	   (eg:	   Ngns,	   SoxC	   and	   SoxB2).	   Genes	   involved	   in	   axon	   formation	   (eg:	  Stmn1)	   and	   neurite	   development	   (eg:	   Chl1	   and	   Slit)	   were	   observed.	   Genes	  involved	   in	   bone	   development	   and	   chromatin	   organization	  were	   up	   regulated.	  Clusters	  related	  with	  chromatin	  organization	  were	  formed	  by	  histone	  genes	  such	  as	  Hist1H4M	  and	  Hist2H3C1	  (Figure	  4.6	  A	  and	  A’).	  Under	   the	   Sox9	   knock	   down	   condition,	   genes	   involved	   in	   cell	   cycle	  regulation	   were	   down	   regulated	   (eg:	   Cyclin	   A2,	   Cyclin	   B1	   and	   Cdc2A).	   Genes	  related	   with	   blood	   vessel	   development,	   bone	   development	   and	   neuron	  differentiation	  were	  up	  regulated	  (Figure	  4.6	  B	  and	  B’).	  The	  cluster	  related	  with	  neuronal	   differentiation	   did	   not	   contain	   neuronal	   specific	   genes	   such	   as	   Ngn,	  SoxC	  or	  SoxB2.	  Ephrin	  receptor	  genes	  were	  observed	   in	   the	  group	  (EphB1	  and	  EphA1).	  	  Under	   the	   Sox8-­‐Sox9	   double	   KD	   condition,	   similar	   to	   Sox9	   KD,	   genes	  related	  to	  cell	  cycle	  regulation	  were	  down	  regulated	  (cyclin	  family	  members,	  cell	  division	   control	   protein	   members	   and	   cell	   division	   control	   associated	   protein	  members).	  Genes	  that	  were	  up	  regulated	  were	  annotated	  into	  clusters	  involved	  in	  diverse	   functions	  (Figure	  4.6	  C	  and	  C’).	  The	  results	  will	  be	  discussed	   further	  later.	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Figure	  4.6:	  Gene	  Ontology	  (GO)	  analysis	  of	  Ascl1	  downstream	  genes	  Enrichment	   of	   Gene	   Ontology	   biological	   process	   terms	   in	   SoxE	   downstream	  genes	   in	   NS5	   cells.	   Number	   of	   genes	   in	   each	   category	   is	   shown.	   Functional	  clusters	   for	  down-­‐regulated	  (A,	  B	  and	  C)	  and	  up-­‐regulated	  genes	  (A’,	  B’	  and	  C’)	  were	  manually	  grouped	  based	  on	  boarder	  GO	  terms.	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4.3.5	  SoxE	  regulates	  genes	  involved	  in	  cell	  cycle	  regulation	  	  As	  shown	  in	  my	  earlier	  experiments,	  SoxE	  activity	  is	  potentially	  involved	  in	   maintaining	   NSC	   proliferation	   in	   vitro	   (Figure	   4.4).	   Also,	   genome-­‐wide	  expression	  microarray	  data	  and	  GO	  analysis	  have	  shown	  that	  SoxE	  downstream	  genes	  are	   involved	   in	  cell	  cycle	  regulation	  (Figure	  4.6,	  data	  not	  shown).	  Here,	   I	  decided	  to	  focus	  on	  this	  group	  of	  genes.	  	  Functional	   clusters	   related	   with	   cells	   cycle	   regulation	   were	   manually	  selected	   (in	  order	   to	  pick	  up	  all	   cell	   cycle	   regulation	  genes,	   the	  p-­‐values	  of	   the	  functional	  clusters	  were	  not	  considered	  at	  this	  point).	  	  Under	  the	  Sox8	  KD	  condition,	  14	  cell	  cycle	  related	  genes	  were	  identified	  (13	  down-­‐regulated	  and	  1	  up-­‐regulated).	  Under	   the	  Sox9	  KD	  condition,	  41	   cell	  cycle	   related	  genes	  were	  deregulated	   (32	  down	  regulated	  and	  9	  up	   regulated).	  Under	   the	  double	  KD	  condition,	  56	   cell	   cycle	   related	  genes	  were	   regulated	   (51	  down	   regulated	   and	   5	   up	   regulated).	   6	   genes	   were	   commonly	   deregulated	   by	  Sox8	  and	  Sox9,	  but	  majority	  of	  the	  cell	  cycle	  related	  genes	  downstream	  of	  Sox8	  or	   Sox9	   were	   different.	   24	   genes	   were	   deregulated	   under	   the	   double	   KD	  condition,	   which	   suggested	   functional	   redundancy	   between	   the	   two	   SoxE	  members	  (Figure	  4.7	  A).	  	  Individual	   genes	   were	   manually	   fitted	   into	   different	   phases	   of	   the	   cell	  cycle	  process	  based	  on	   the	  known	   functions	   (http://www.uniprot.org/).	   It	  was	  clear	  that	  SoxE	  downstream	  were	  related	  with	  multiple	  phases	  of	  the	  cell	  cycle,	  including	  phase	  transitions	  (Figure	  4.7	  B-­‐D).	  The	  results	  will	  be	  discusses	  further	  in	  a	  later	  section.	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Figure	  4.7:	  SoxE	  downstream	  genes	  are	  involved	  in	  cell	  cycle	  regulation	  List	   of	   SoxE	   downstream	   genes	   involved	   in	   cell	   cycle	   regulation	   based	   on	  functional	   annotation	   analysis	   (A).	   The	   distribution	   of	   Sox8	   (B),	   Sox9	   (C)	   and	  SoxE	  (D)	  downstream	  cell	  cycle	  related	  genes	  in	  the	  cell	  cycle	  process.	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4.3.6	  Sox9	  directly	  regulate	  cell	  cycle	  related	  genes	  Taking	   the	   advantage	   that	   the	   ChIP-­‐Seq	   experiment	   using	   NS5	   cells	   as	  starting	  material	  was	  performed	  previously	  (Ben	  Martynoga,	  unpublished	  data),	  I	   identified	   513	   direct	   targets	   of	   Sox9.	   Furthermore,	   21	   out	   of	   41	   cell	   cycle	  related	   genes,	   which	   was	   identified	   by	   the	   expression	  microarray	   were	   direct	  targets	  of	  Sox9	  (Figure	  4.8	  A).	  This	  confirmed	  that	  Sox9	  was	  directly	  involved	  in	  NSC	   cell	   cycle	   regulation	   in	   vitro.	   Furthermore,	   Sox9	   targets	   involved	   in	   cell	  proliferation	  were	   involved	   in	  multiple	   stages	   of	   the	   cell	   cycle	   process	   (Figure	  4.8	  B).	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Figure	  4.8:	  Sox9	  target	  genes	  were	  involved	  in	  cell	  cycle	  regulation	  Identification	   of	   Sox9	   target	   genes	   (A).	   The	   distribution	   of	   the	   21	   cell	  proliferation	  related	  Sox9	  target	  genes	  in	  cell	  cycle	  process	  (B).	  	  	  	  	  
	   79	  
4.4	  Uncovering	  molecular	  mechanisms	  of	  SoxE	  in	  regulating	  NSC	  
proliferation	  My	   pervious	   experiments	   have	   shown	   SoxE	   activity	   is	   essential	   to	  maintain	  NSC	  proliferation	   in	   vitro	   (Figure	  4.4).	  Genome-­‐wide	  gene	  expression	  microarray	   and	   ChIP-­‐Seq	   analysis	   are	   consistent	   with	   this	   observation	   and	  further	  suggest	  that	  SoxE	  regulates	  cell	  cycle	  related	  genes	  in	  a	  direct	  manner	  (at	  least	  for	  Sox9,	  Figure	  4.7	  and	  Figure	  4.8).	  However,	  the	  molecular	  mechanisms	  of	  SoxE	   in	   regulating	   cell	   proliferation	   remain	   unclear	   and	   became	   my	   next	  question.	  However,	  downstream	  and	  target	  genes	  of	  Sox8	  and	  Sox9	  related	  with	  cell	  proliferation	  are	  distributed	  across	  the	  entire	  cell	  cycle	  process	  (Figure	  4.7	  and	  Figure	  4.8).	  In	  order	  to	  identify	  the	  most	  critical	  downstream	  or	  target	  genes	  involved	   in	   this	   process,	   subsequently	   the	  molecular	  mechanism,	   the	   cell	   cycle	  dynamic	  needed	  to	  be	  assessed.	  Immunocytochemistry	  and	  flow	  cytometry	  were	  used	  to	  examine	  the	  cell	  cycle	  dynamic	  under	  the	  SoxE	  LoF	  conditions.	  	  	  
4.4.1	  SoxE	  is	  involved	  in	  G1/S	  transition	  To	  assess	  SoxE	  activity	  in	  controlling	  cell	  cycle	  dynamics,	  NS5	  cells	  were	  transfected	  with	  shRNA	  against	  Sox8	  or/and	  Sox9.	  EdU	  containing	  medium	  was	  applied	   48h	   post	   transfection	   and	   cells	   were	   fixed	   at	   different	   time	   points	  (Figure	  4.9	  A).	  	  Under	  the	  control	  condition,	  the	  labelling	  index	  (LI)	  (the	  number	  of	  GFP-­‐EdU	   double	   positive	   cells	   divided	   by	   the	   total	   number	   of	   GFP-­‐positive	   cells)	  progressively	  increased	  up	  to	  13.38h	  (point	  A,	  Figure	  4.9	  B).	  This	  corresponded	  to	  the	  growth	  fraction	  (GF),	  indicating	  that	  88.57%	  of	  the	  GFP-­‐positive	  cells	  were	  proliferating.	   The	   data	   (Figure	   4.9	   B,	   blue	   line)	   could	   be	   described	   by	   two	  regression	   lines:	   the	   linear	   line	   increased	   in	   cell	   labeling	   between	   20	  min	   and	  13.38h	  (y=4.754*x	  +	  25.06)	  and	  the	  horizontal	  line	  between	  13.38h	  and	  30h.	  The	  time	  (point	  A)	  when	  the	  two	  lines	  intersect	  equals	  Tc−	  Ts	  =	  13.38h.	  The	  intersect	  of	  the	  linear	  line	  with	  the	  y	  axis	  was	  defined	  as	  the	  initial	  labeling	  index	  (LI0)	  and	  corresponds	  to	  GF	  ×Ts/Tc.	  For	  my	  data,	  LI0	  was	  25.06,	  suggesting	  25.06%	  of	  the	  GFP-­‐positive	   cells	   were	   in	   the	   S-­‐phase	   at	   T0.	   From	   these	   three	   equations,	   I	  calculated	  a	  Tc	  of	  18.77h	  and	  a	  Ts	  of	  5.28h	  for	  the	  GFP-­‐positive	  cells	  (Figure	  4.9	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B).	  Under	   the	   SoxE	  knock	  down	   condition,	   the	   LI	   slowly	   increased	  but	   did	  not	  reach	  the	  GF	  within	  30h.	  The	  slow	  increasing	  linear	  lines	  (Sox8	  KD:	  y=0.4330*x	  +	  7.272;	  Sox9	  KD:	  y=0.8159*x	  +	  10.30;	  Sox8-­‐Sox9	  double	  KD:	  y=0.2072*x	  +	  6.057)	  indicated	   that	   the	   LI0	   for	   Sox8	   KD,	   Sox9	   KD	   and	   Sox8-­‐Sox9	   double	   KD	   were	  7.272,	  10.30	  and	  6.057.	  The	  GF	  for	  cells	  under	  LoF	  conditions	  was	  estimated	  as	  88.58%	  and	  the	  Tc	  and	  Ts	  were	  calculated	  as	  described	  above	  (Figure	  4.9	  B).	  These	  data	  suggest	  that	  SoxE	  is	  required	  for	  G1-­‐phase	  progression	  or/and	  G1/S	  transition	  during	  NSC	  proliferation.	  This	  will	  be	  discussed	  further	  in	  a	  later	  section.	  	  	  
4.4.2	  SoxE	  activity	  is	  not	  required	  for	  mitosis	  	  To	  assess	  whether	  SoxE	  activity	  was	  involved	  in	  mitosis,	  antibody	  against	  pHH3	  (a	  marker	  for	  late	  G2	  and	  M-­‐phase)	  was	  used	  to	  visualize	  the	  process.	  	  Immunocytochemistry	  was	  performed	  48h	  post-­‐transfection	  (Figure	  4.10	  A).	  Under	  the	  control	  condition,	  pHH3	  expression	  was	  detected	  at	  late	  G2/early	  M	  phase	  (prophase,	  Figure	  4.10	  B)	  and	  late	  M	  phase	  (cytokinesis,	  Figure	  4.10	  B’).	  SoxE	   LoF	   did	   not	   have	   clear	   effect	   on	   the	   M-­‐phase	   as	   both	   prophase	   and	  telophase/cytokinesis	  appeared	  to	  be	  normal	  under	  single	  and	  double	  SoxE	  KD	  conditions	   (Figure	  4.10	  C	   to	  E’).	  However,	  SoxE	  LoF	  reduced	   the	  percentage	  of	  cells	   entered	   the	   M-­‐phase.	   Under	   Sox8	   single	   and	   Sox8-­‐Sox9	   double	   KD	  conditions,	   the	  percentage	  was	   reduced	  by	  more	   than	  60%.	  The	  percentage	   of	  cells	  entered	   the	  M-­‐phase	  was	  reduced	  by	  50%	  under	   the	  Sox9	  LoF	  conditions	  (Figure	  4.10	  F).	  	  The	  data	  suggest	  that	  SoxE	  is	  not	  involved	  in	  mitosis	  directly	  and	  this	  will	  be	  further	  discussed	  later.	  	  	  	  
	   81	  
	  
Figure	   4.9:	   SoxE	   is	   required	   for	   G1/S	   transition	   during	   cell	   cycle	  
progression	  Experimental	  design	  of	  the	  cumulative	  labelling	  (CL)	  method	  (A).	  Length	  of	  cell	  cycle	  phases	  under	   control	   (blue	   line),	   Sox8	  KD	   (brown	   line),	   Sox9	  KD	   (purple	  line)	  and	  Sox8-­‐Sox9	  double	  KD	  (red	  line)	  conditions	  were	  calculated	  using	  the	  LI	  data.	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Figure	  4.10:	  SoxE	  activity	  was	  not	  involved	  in	  mitosis	  Experimental	  design	  (A).	  Expression	  of	  pHH3	  (red)	  in	  late	  G2/early	  M	  phase	  and	  late	  M	  phase	  under	  control	  (B	  and	  B’),	  Sox8	  KD	  (C	  and	  C’),	  Sox9	  KD	  (D	  and	  D’)	  and	  Sox8-­‐Sox9	  double	  KD	  (E	  and	  E’).	  The	  quantification	  graph	  shows	  percentage	  pHH3-­‐GFP	  double	  positive	  cells	  48h	  post-­‐transfection	  (F).	  Data	  shown	  are	  mean	  of	  three	  independent	  biological	  replicates.	  Error	  bar:	  mean	  ±	  SEM.	  t	  test:	  *p<0.05.	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4.4.3	   Cell	   cycle	   analysis	   using	   fluorescence-­activated	   cell	   sorting	   (FACS)	  
analysis	  In	   parallel	   with	   immunocytochemistry,	   FACS	   analysis	   was	   used	   as	   a	  second	   approach	   to	   assess	   cell	   cycle	   dynamic.	   Based	   on	   DNA	   content,	   FACS	  analysis	   is	   able	   to	  define	   the	  percentage	  of	   cells	   at	  G1/G0,	   S	   and	  G2/M	  phases	  within	  the	  population.	  The	  accumulation	  of	  cells	  in	  a	  particular	  phase	  of	  cell	  cycle	  after	   SoxE	   KD	   would	   be	   helpful	   to	   identify	   potential	   candidates	   for	  understanding	  molecular	  mechanism	  of	  SoxE	  in	  regulating	  NSC	  proliferation.	  My	  preliminary	  data	  suggested	  the	  cells	  were	  potentially	  stuck	  at	  G1/G0-­‐phase	  and	  I	  was	  expecting	  an	  accumulation	  of	  G1/G0	  cells	  during	  the	  experiment	  (see	  4.3.2	  for	  details).	  	  NS5	   cells	   transfected	  with	   Sox8	  or/and	  Sox9	   shRNA	  were	   collected	  72h	  post	  transfection	  with	  56h	  puromycine	  selection	  (Figure	  4.11	  A).	  FACS	  analysis	  profile	  showed	  the	  distribution	  of	  transfected	  cells	  in	  different	  phases	  during	  cell	  cycle	   under	   the	   control	   condition	   (G0/G1:	   73%;	   S:	   12.7%;	   G2/M:	   12%,	   Figure	  4.11	  B).	  Surprisingly,	   the	  distribution	  profiles	   for	  both	  single	  and	  double	  knock	  down	   conditions	  were	   similar	   to	   control	   (Figure	   4.11	  B’,	   B’’	   and	  B’’’).	   No	   clear	  accumulation	  of	  cells	  in	  any	  of	  the	  cell	  cycle	  phases	  was	  observed	  under	  the	  KD	  conditions	  (Figure	  4.11	  C).	  The	  data	  from	  FACS	  analysis	  was	  not	  consistent	  with	  earlier	  experiments,	  which	  showed	  a	  smaller	  number	  of	  cells	  had	  entered	  S	  and	  M	  phases	  (Figure	  4.9,	  see	   4.3.2	   for	   details).	   Till	   this	   point,	   I	   do	   not	   have	   other	   explanations	   but	  technique	  issues	  (eg:	  cell	  fixation)	  to	  explain	  the	  results.	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Figure	  4.11:	  Cell	  cycle	  analysis	  under	  SoxE	  KD	  conditions	  Experimental	   design	   (A).	   FACS	   analysis	   profiles	   for	   control	   (B),	   Sox8	   KD	   (B’),	  Sox9	  KD	  (B’’)	  and	  Sox8-­‐Sox9	  double	  KD	  (B’’’).	  The	  quantification	  graph	  shows	  the	  distribution	  of	  transfected	  cells	  in	  different	  phases	  of	  the	  cell	  cycle.	  Data	  shown	  are	  mean	  of	  two	  independent	  biological	  replicates.	  Error	  bar:	  mean	  ±	  SEM.	  	  
	   85	  
4.5	   Regulation	   between	   SoxE	   and	   Ascl1	   and	   within	   the	   SoxE	  
members	  As	   mentioned	   earlier,	   Sox8	   regulates	   Ascl1	   activity	   in	   an	   enhancer	  dependent	  manner	  (Cristina	  Minieri,	  unpublished	  data)	  and	  interact	  with	  Ascl1	  at	  the	  protein	  level	  (Debbie	  van	  den	  Berg,	  unpublished	  data).	  q-­‐PCR	  was	  used	  to	  assess	  whether	  Sox8	  and	  Sox9	  were	  able	  to	  regulate	  Ascl1	  expression	  directly.	  I	  also	  noticed	  cross	  regulation	  between	  the	  two	  SoxE	  members.	  	  RNA	  samples	  were	  collected	  48h	  and	  72h	  post-­‐transfection	  with	  32h	  and	  56h	  puromycine	   selection	   (Figure	  4.12	  A).	  q-­‐PCR	  analysis	   showed	  a	   significant	  reduction	   of	   Ascl1	   expression	   under	   both	   single	   and	   double	   KD	   conditions	   at	  both	   time	   points	   (for	   Sox8	   KD	   at	   48h,	   a	   25%	   reduction	   was	   observed).	   This	  suggested	  the	  possibility	  SoxE	  positively	  regulate	  Ascl1	  expression	  at	  least	  at	  the	  RNA	  level	  (Figure	  4.12	  B).	  	  Furthermore,	   under	   the	   Sox8	  KD	   condition,	   the	   expression	   of	   Sox9	  was	  up-­‐regulated	  by	  1.4-­‐fold	  48h	  post-­‐transfection.	  At	  the	  72h	  time	  point,	  a	  3.5-­‐fold	  increase	  was	   observed.	   This	   suggested	   Sox8	   repressed	   Sox9	   expression	   at	   the	  RNA	  level	  (Figure	  4.12	  C).	  On	  the	  other	  hand,	  Sox8	  expression	  was	  not	  effected	  by	  Sox9	  DK	  (data	  not	  shown).	  These	  results	  will	  be	  discussed	  in	  a	  later	  section.	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Figure	  4.12:	  Regulation	  between	  SoxE	  members	  and	  Ascl1	  Experimental	  design	  (A).	  q-­‐PCR	  analysis	  to	  assess	  Ascl1	  expression	  48h	  and	  72h	  post-­‐transfection	  under	   SoxE	  KD	   conditions	   (B).	   q-­‐PCR	  analysis	   to	   assess	   Sox9	  expression	   under	   the	   Sox8	   LoF	   condition.	   Data	   shown	   are	   mean	   of	   three	  independent	   biological	   replicates.	   Error	   bar:	   mean	   ±	   SEM.	   t	   test:	   **p<0.01;	  ***p<0.001;	  ****p<0.0001	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4.6	  Discussion	  	  In	   this	   chapter,	   I	   have	   shown	   that	   ectopic	   expression	   of	   Sox8	   or	   Sox9	  inhibit	   Ascl1-­‐induced	   neuronal	   differentiation	   in	   vitro.	   Furthermore,	   my	  preliminary	  data	  has	  also	  shown	  that	  Sox8	  and	  Sox9	  have	  essential	  functions	  in	  maintaining	   NSC	   proliferation	   in	   vitro,	   potentially	   via	   regulating	   G1	   phase	  progression	   or/and	   G1/S	   transition.	   Here,	   I	   will	   discuss	   these	   preliminary	  findings.	  	  
4.6.1	  SoxE	  inhibits	  Ascl1-­mediated	  NSC	  differentiation	  in	  vitro	  My	   GoF	   studies	   have	   shown	   that	   Sox8	   and	   Sox9	   negatively	   regulated	  Ascl1-­‐induced	   NSC	   neuronal	   differentiation	   in	   vitro.	   This	   observation	   is	  consistent	  with	  a	  number	  of	  published	  studies,	  which	  indicate	  Sox8	  or/and	  Sox9	  inhibit	  cell	  differentiation	  in	  different	  tissues.	  In	  CNS,	  Sox9	  GoF	  inhibits	  neuronal	  differentiation	   in	   developing	  mouse	   telencephalon	   (Scott	   et	   al,	   2010).	   In	   other	  tissues,	   Sox8	  acts	   as	  negatively	   regulator	  osteoblast	  differentiation	   (Schmidt	  et	  al,	  2005);	  both	  Sox8	  and	  Sox9	  inhibit	  MyoD-­‐induced	  myogenesis	  (Schmidt	  et	  al,	  2003).	  Sox8	  or	  Sox9	  GoF	  reduces	  the	  Ascl1-­‐induced	  NSC	  neuronal	  differentiation	  
in	  vitro	  suggests	  two	  possibilities:	  SoxE	  down	  regulate	  Ascl1	  expression	  directly	  or	  inhibits	  Ascl1-­‐induced	  activation	  of	  neuronal	  specific	  targets.	  	  Genome	   wide	   expression	   microarray	   data	   has	   shown	   that	   Sox8	   is	   up	  regulated	   during	   Ascl1-­‐induced	   NS5	   cell	   differentiation	   (Ben	   Martynoga,	  unpublished	   data).	   Furthermore,	   SoxE	   LoF	   experiment	   shows	   a	   reduction	   of	  Ascl1	  expression	   (Figure	  4.12	  B).	  These	   suggest	   that	  Sox8	  and	  Ascl1	  positively	  regulate	  each	  other	  at	  the	  transcriptional	  level.	  I	  do	  not	  have	  direct	  evidence	  to	  indicate	   that	   Sox9	   is	   regulated	   by	   Ascl1	   expression.	   Indeed,	   Sox9	   is	   down	  regulated	   during	   Ascl1-­‐induced	   NS5	   cell	   differentiation	   (Ben	   Martynoga,	  unpublished	  data),	  but	  this	  potentially	  due	  to	  the	  up-­‐regulation	  of	  Sox8.	  On	  the	  other	   hand,	   luciferase	   reporter	   assay	   indicates	   that	   Sox8	   GoF	   inhibits	   Ascl1	  activity	  in	  an	  enhancer	  dependent	  manner	  (Cristina	  Minieri,	  unpublished	  data).	  These	   date	   suggest	   the	   possibility	   that	   Sox8	   inhibits	   Ascl1-­‐induced	   neuronal	  differentiation	   via	   blocking	   activities	   of	   Ascl1	   target	   genes	   in	   vitro.	   No	   direct	  evidence	  to	  suggest	  Sox9	  is	  able	  to	  control	  the	  activity	  of	  Ascl1	  targets.	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Here,	  the	  data	  raise	  the	  possibility	  that	  SoxE	  (at	  least	  Sox8)	  inhibit	  Ascl1-­‐induced	  neuronal	  differentiation	  via	  direct	  inhibition	  of	  Ascl1	  expression	  or/and	  controlling	  Ascl1	  target	  genes.	  	  	  
4.6.2	  Sox8	  and	  Sox9	  are	  essential	  and	  have	  partial	   functional	  redundancy	  
in	  maintaining	  NSC	  proliferation	  in	  vitro	  My	  preliminary	  data	  has	  shown	  that	  Sox8	  and	  Sox9	  have	  critical	  functions	  to	   maintain	   NSC	   in	   a	   proliferative	   state.	   The	   significant	   reduction	   of	   cell	  proliferation	   (Figure	   4.4	   and	   Figure	   4.9)	   under	   single	   KD	   conditions	   indicates	  that	  Sox8	  and	  Sox9	  cannot	  compensate	  each	  other	  to	  maintain	  NSC	  proliferation.	  On	   the	   other	   hand,	   the	   double	   KD	   indeed	   has	   an	   enhanced	   phenotype	   in	  inhibiting	   NSC	   proliferation	   comparing	   with	   Sox8	   or	   Sox9	   single	   knock	   down	  (Figure	   4.4	   and	   Figure	   4.9).	   These	   data	   indicate	   that	   SoxE	  members	   only	   have	  partial	   functional	   redundancy	   in	   maintaining	   NSC	   proliferation.	   This	   is	   also	  indicated	  in	  my	  genome	  wide	  expression	  microarray	  data	  (see	  4.6.3	  for	   further	  discussion).	  	  The	  observation	   that	   Sox8	   and	  Sox9	  have	  partial	   functional	   redundancy	  raises	  two	  hypotheses	  to	  predict	  the	  molecular	  mechanisms	  of	  Sox8	  and	  Sox9	  in	  regulating	   cell	   proliferation.	   Firstly,	   Sox8	   and	   Sox9	   share	   common/similar	  downstream	   genes,	   which	   are	   involved	   in	   maintaining	   NSC	   proliferation	   (eg:	  Cdc2a	   and	   Cdkn1a;	   Figure	   4.7).	   The	   enhanced	   phenotype	   in	   inhibiting	  proliferation	   in	   the	   double	   knock	   down	  may	   due	   to	   further	   reduction	   of	   SoxE	  activities.	   Secondly,	   Sox8	   and	   Sox9	   regulate	   different	   sets	   of	   genes	   that	   give	  similar	  phenotype.	  For	  example,	  Skp2,	  an	  E3	  ubiquitin	  ligase	  that	  is	  essential	  for	  G1/S	   transition	   is	   down	   regulated	   under	   Sox8	   LoF	   condition	   (Figure	   4.7).	  Gadd45a,	  which	   inhibits	   cells	   entering	  S-­‐phase	   is	  up	   regulated	  under	  Sox9	  LoF	  condition	  (Figure	  4.7).	  The	  enhanced	  phenotype	  in	  the	  double	  knock	  down	  may	  due	  to	  the	  combination	  of	  the	  two	  activities.	  However,	  I	  have	  not	  had	  any	  direct	  evidence	  to	  support	  either	  hypothesis.	  	  	  
4.6.3	  Identification	  and	  functional	  annotation	  of	  SoxE	  downstream	  genes	  Genome	  wide	  expression	  microarrays	  was	  used	  to	  detect	  gene	  expression	  changes	   under	   SoxE	   LoF	   conditions.	   Under	   the	   single	   KD	   conditions,	   genes	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deregulated	   by	   either	   Sox8	   LoF	   or	   Sox9	   LoF	   indicates	   that	   the	   two	   members	  regulate	  different	   set	   of	   genes	   and	   subsequently	  have	  different	   functions.	   Sox8	  and	  Sox9	  have	  highly	   conserved	  DNA	  binding	  HMGs	  and	  binding	  motif	   (Figure	  4.1),	   the	  difference	   in	  optimal	  binding	   sequence	  partly	   explain	   the	  observation	  from	  the	  microarray	  data	  (Figure	  4.5)	  and	  the	  GO	  analysis	  (Figure	  4.6).	  	  Genes	  deregulated	  under	   the	  double	  KD	  only	   are	   redundantly	   regulated	  by	  Sox8	  and	  Sox9.	  However,	  714	  genes	  are	  deregulated	  under	  the	  single	  KD	  but	  not	   the	  double	  KD	   (Figure	  4.5).	  There	   are	   two	  potential	   sources	   for	   this	   set	   of	  genes.	  Firstly,	  genes	  are	  deregulated	  to	  opposite	  directions	  under	  Sox8	  and	  Sox9	  single	   KD	   conditions.	   For	   example,	   Sox9	   is	   up	   regulated	   under	   the	   Sox8	   KD	  condition.	  Only	  19	  genes	  are	  regulated	  in	  this	  manner.	  Variations	  in	  KD	  efficiency	  between	  biological	  replicates	  and	  between	  single	  and	  double	  KD	  (Figure	  4.5)	  is	  major	   source	   for	   this	   set	   of	   genes.	   This	   technique	   issue	   cannot	   be	   eliminated	  under	  current	  in	  vitro	  KD	  system.	  Similar	  observation	  can	  be	  found	  for	  cell	  cycle	  genes	  (Figure	  4.7).	  	  
4.6.4	  SoxE	  activity	  is	  involved	  in	  G1-­phase	  progression	  and	  G1/S	  transition,	  
but	  not	  mitosis	  The	  CL	  experiment	  has	  shown	  that	  cells	  under	  SoxE	  KD	  conditions	  (both	  singles	   and	   double	   KD)	   have	   lower	   LI0	   values	   and	   slower	   LI	   increase,	   which	  unable	  to	  reach	  GF	  of	  the	  control	  population	  within	  the	  given	  time.	  These	  suggest	  that	   the	  percentage	  of	   cells	  has	  entered	  S-­‐phase	   is	  much	   lower	  under	  SoxE	  KD	  conditions	  and	  the	  cells	  are	  unable/slowly	  pass	  G1/S	  checkpoint	  to	  complete	  cell	  cycle	  (Figure	  4.9).	  Furthermore,	  as	  cells	  are	  able	  to	  go	  through	  mitosis	  normally	  under	  SoxE	  KD	  conditions,	  suggesting	  Sox8	  and	  Sox9	  are	  not	  directly	  involved	  in	  regulating	  M-­‐phase	  (Figure	  4.10).	  	  The	  data	  raise	  the	  possibility	  that	  SoxE	  members	  have	  critical	  functions	  in	  regulating	  G1	  progression	  or/and	  G1/S	  transition	  during	  the	  cell	  cycle.	  Pervious	  studies	  have	  shown	  that	  Sox9	  regulates	  the	  proliferation	  of	  primary	  cells	  (MEFs)	  via	  controlling	  cells	  cycle	  progression	  from	  G1	  to	  S-­‐phase	  (Matheu	  et	  al,	  2012).	  My	  data	   is	  consistent	  with	   the	  pervious	  observation.	  Although	  the	  experiments	  were	  performed	  using	   two	  different	   in	  vitro	   systems,	  Sox9	  may	  still	  potentially	  regulate	  similar	  target	  genes	  to	  control	  cell	  cycle	  progression	  in	  both	  systems.	  In	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combination	   with	   my	   expression	   microarray	   data,	   potential	   candidate(s)	   for	  uncovering	   the	  molecular	  mechanism	   should	   be	   primarily	   selected	   from	  genes	  involved	  in	  G1-­‐phase	  progression	  and	  G1/S	  transitions	  (eg:	  Cdk1,	  Cdkn1a,	  Skp2;	  Figure	   4.7).	   However,	   till	   this	   point,	   whether	   similar/same	   molecular	  mechanism(s)	   is	   used	   by	   Sox8	   and	   Sox9	   to	   control	   cell	   cycle	   progression	   is	  unclear	   and	   further	   investigation	   is	   required.	   However,	   whether	   the	   cells	  entered	  the	  S-­‐phase	  are	  able	  to	  complete	  the	  cell	  cycle	  has	  yet	   to	  be	  confirmed	  using	  double	  thymidine	  analog	  (DA)	  method.	  	  Furthermore,	   the	   lower	  percentage	  of	   cells	   in	  S	  phase	   (lower	  LI0	  value)	  under	   the	   KD	   conditions	   suggests	   that	   a	   sub	   population	   of	   cells	   is	   unable	   to	  proliferate	   and	   stuck	   at	   G1/G0	   phase	   (as	   SoxE	   is	   potentially	   control	   G1	  progression	   or/and	   G1/S	   transition.	   However,	   whether	   the	   cells	   exit	   the	   cell	  cycle	  and	  enter	  G0	  phase	  is	  unclear).	  On	  the	  other	  hand,	  the	  slow	  increase	  of	  LI	  under	   the	  KD	   conditions	   indicates	   a	   sub	  population	  of	   transfected	   cells	   indeed	  can	  proliferate,	  but	  slowly	  (Figure	  4.9).	  These	  suggest	  that	  the	  transfected	  cells	  can	  be	  divided	  into	  two	  populations:	  the	  non-­‐proliferating	  and	  slow	  proliferating	  populations.	  This	  can	  be	  partly	  explained	  by	  the	  experimental	  approach.	  One	  of	  disadvantages	  of	  the	  shRNA-­‐mediated	  KD	  is	  the	  variation	  in	  KD	  efficiency.	  Even	  within	   a	   single	   transfection	   reaction,	   the	   KD	   efficiency	   between	   individual	  transfected	  cells	  is	  potentially	  different,	  which	  is	  indicated	  by	  the	  variation	  in	  the	  GFP	  signal	  intensity	  (Figure	  4.4).	  The	  cells	  with	  high	  KD	  efficiency	  are	  potentially	  the	  source	  of	  the	  non-­‐proliferating	  cells	  and	  cells	  with	  low	  KD	  efficiency	  may	  still	  proliferate,	  but	  slowly.	  	  My	  preliminary	  results	  have	  shown	  that	  SoxE	  is	  not	  directly	  required	  for	  mitosis,	  as	  both	  prophase	  and	  telophase/cytokinesis	  are	  not	  affected	  under	  SoxE	  KD	  conditions	  (Figure	  4.10).	  This	  indicates	  that	  SoxE	  downstream/target	  genes	  related	   with	   M-­‐phase	   progression	   are	   not	   directly	   responsible	   to	   control	   NSC	  proliferation	  (Figure	  4.7).	  Indeed,	  the	  percentage	  of	  transfected	  cells	  entering	  S-­‐phase	  is	  reduced	  by	  more	  than	  50%	  (Figure	  4.9),	  which	  can	  be	  partly	  explained	  by	   the	  presence	  of	  non-­‐proliferating	  cells	   (see	  above	   for	  details).	  Furthermore,	  the	   expression	   of	   pHH3	   starts	   from	   late	   G2	   phase	   and	   the	   reduced	   number	   of	  pHH3-­‐positive	   cells	   suggests	   less	   cells	   have	   entered	   (late)	   G2	   phase.	   This	   is	  
	   91	  
consistent	  with	   the	  hypothesis	   that	  SoxE	  regulate	  NSC	  cell	  cycle	  via	  controlling	  G1	  phase	  progression	  or/and	  G1/S	  transition.	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